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SUMMARY 
Polycomb group (PcG) proteins repress transcription of many developmental 
regulator genes including homeotic selector (Hox) genes in multicellular organisms. 
PcG proteins form a variety of distinct multimeric complexes and modify target 
chromatin. For instance, the Polycomb repressive complex 2 (PRC2) consists of E(z), 
Su(z)12, Esc and Nurf55 as core subunits, and the complex mono-, di-, and tri-
methylates histone H3 lysine 27  (H3K27me1/2/3). The H3K27me3 is critical for 
repression of Polycomb target genes. In order to generate sufficiently high levels of 
H3K27me3 at Polycomb target genes in vivo, PRC2 requires being associated with 
accessory subunits such as Polycomblike (Pcl). To date, the molecular mechanism of 
Pcl in the PRC2 has remained elusive. Here I show the crystal structure of conserved 
central domains of Pcl in Drosophila melanogaster (Dm), uncovering the presence of 
a winged-helix (WH) domain. I demonstrate that Dm Pcl and its human homologue 
PHF1 bind DNA via the conserved WH domain, and that this binding increases DNA 
binding of PRC2 in the context of a PHF1-PRC2 complex. In addition, I show that a 
conserved C-terminal domain of PHF1 is crucial for the PHF1 to form a stable 
complex with PRC2. Moreover, I present that the PHF1 WH and C-terminal domains 
enhance nucleosome binding of PRC2, and this is pivotal for generating high levels of 
H3K27me3 by PRC2 in vitro. Taken together, this study provides molecular insight 
into how the Pcl/PHF1 promotes H3K27 methylation by PRC2. 
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I. INTRODUCTION 
1. EARLY DEVELOPMENT IN EUKARYOTES 
In eukaryotes, meticulous gene regulation during development is crucial to 
establish and maintain cell fates. Extensive studies of early development in 
Drosophila melanogaster (Dm; many studies, collected in Gilbert, 2014) have helped 
our understanding of the eukaryotic cell fate decisions to a great extent.  
Early Dm embryos undergo nuclear divisions (karyokinesis) for 13 cycles without 
cell divisions (cytokinesis) generating a syncytium. At the nuclear division cycle 10, 
the nuclei migrate to the periphery of the embryos, and the embryos at this stage are 
called the syncytial blastoderm. After the division cycle 13, the cell membrane folds 
inwardly to partition the nuclei off and creates the cellular blastoderm (Gilbert, 2014; 
Figure 1).  
 
Figure 1. Syncytial nuclear divisions and migrations in the Dm embryo 
Laser confocal micrograph of Dm embryos with stained chromatin; numbers indicate the cell 
division cycles (1 to 14); A, anterior; P, posterior; the figure was adapted from Gilbert, 2014. 
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In the early Dm embryo, maternal effect genes specify cell fates, and 
segmentation genes determine the cell fates (Figure 2). In sections below, I provide a 
brief overview of the early development of Dm anterior (A)-posterior (P) body plan. 
 
Figure 2. Anterior-posterior pattern formation in the early Dm embryo 
Left: simplified scheme of homeotic gene regulation during the early Dm embryo development; 
PcG, Polycomb group; TrxG, Trithorax group; blue arrows indicate activation of gene 
expression; red, repression; middle: some examples of early maternal or zygotic gene 
expressions in the Dm embryo (embryo cartoons from http://www.mun.ca/biology/desmid/ 
brian/BIOL3530/DEVO_02/devo_02.html); right: the nuclear division cycle of which each gene 
group starts to be expressed is indicated; please refer Figure 1 for embryo confocal micrographs 
at different division cycles. 
1.  Maternal effect genes 
   
 During oogenesis, the Dm oocyte begins to specify the A-P axis of the body. 
This specification starts with a localization of maternal effect messenger RNA 
(mRNA) by a cellular microtubule network: bicoid  (bcd) mRNA in the anterior tip 
and nanos (nos) in the posterior. Upon fertilization of the oocyte, these maternal 
effect mRNAs are translated into proteins, which diffuse and establish gradients 
along the A-P axis. The Bcd protein forms an A-to-P gradient (Figure 2 and Figure 
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3A), whereas the Nanos a P-to-A gradient (Driever and Nüsslein-Volhard, 1988; 
Wang and Lehmann, 1991).  
 
Figure 3. Maternal effect protein gradients in the 
Dm embryo at different developmental stages. 
Bcd protein localization in the Dm embryo (A) shortly after 
egg deposition; (B) at syncytial blastoderm; (C) at cellular 
blastoderm; A, anterior; P, posterior; figure was adapted 
from (Driever and Nüsslein-Volhard, 1988). 
 
 
2. Segmentation genes 
After the cell fates are specified by maternal effect proteins, the cell fates are 
determined by segmentation gene products. The segmentation genes were first 
identified by which zygotic mutations led to the disruption of the Dm body plan. They 
are classified in three categories: gap genes, pair-rule genes and segment polarity 
genes (Nüsslein-Volhard and Wieschaus, 1980). These genes are expressed in a 
hierarchical manner and regulated by an extensive network of their gene products 
(Figure 2). 
Firstly, at the end of nuclear division cycle 12, the gap genes start to be expressed 
in broad domains along the A-P axis of Dm. The expression is tightly regulated by the 
gradient of maternal effect proteins and gap proteins themselves. Next, upon the 
cycle 13, the pair-rule genes begin to be expressed in every other segment, which will 
develop into each part of the body. The maternal effect and the gap proteins control 
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the expression of pair-rule genes. Hereafter, the first indication of embryo 
segmentation can be observed. Then upon the cycle 14, when the Dm embryo 
undergoes cellularisation and forms the cellular blastoderm, the segment polarity 
genes begin to be expressed in every segment. The pair-rule gene products and the 
segment polarity gene products themselves regulate expression of the segment 
polarity genes. After this, every segmental boundary is set and each segment 
primordium obtains its identity. The segmentation gene products then regulate the 
expression of homeotic selector genes (Hox genes). 
3. Homeotic selector genes 
Hox genes are a group of genes encoding transcription factors that generate 
specific identity of body parts. The Hox genes are highly conserved and their 
expression pattern is similar in almost every bilateral animal (Pearson et al., 2005) 
(Figure 4). In Dm, the Hox genes are clustered in the chromosome 3, consisting of 
Antennapedia and bithorax complex (Lewis, 1978). 
The Hox gene expression is a highly dynamic process throughout the 
development, being controlled not only by segmentation gene products but also by 
the Hox gene products themselves. For instance, Antennapedia (Ant) gene 
expression is repressed by the other Hox proteins such as Ultrabithorax, whose 
spatial expression is posterior to the Ant expression (Gonzalezreyes and Morata, 
1990). 
The segmentation genes are only transiently expressed, thus other factors are 
required to maintain the precise expression pattern of the Hox genes during the 
development. This is where Polycomb group (PcG) and Trithorax group (TrxG) 
proteins come into play: PcG proteins are required for maintaining the repressed 
state of Hox gene expression (Mckeon and Brock, 1991; Simon et al., 1992), whereas 
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TrxG proteins for the active state. More information about the PcG proteins is 
described in detail in the following sections. 
 
Figure 4. Hox gene colinearity 
(A) Expression domains of Hox genes in the Dm embryo at stage 13 (left) and the Mus musculus 
(Mm) embryo at embryonic day 12.5 (right); segment abbreviations; Md, mandibular; Mx, 
maxillary; Lb, labial; T1-T3, thoracic segment 1-3; A1-A9, abdominal segment 1-9; R1-R7, 
rhombomere 1-7; A: anterior; P: posterior. (B) Hox gene loci in Dm and Mm chromosomes; 
gene abbreviations: lab, labial; pb, proboscipedia; zen, zerknullt; bcd, bicoid; Dfd, Deformed; 
Scr, Sex combs reduced; ftz, fushi tarazu; Antp, Antennapedia; Ubx, Ultrabithorax; abd-A, 
abdominal-A; Abd-B, Abdominal-B; schematics were adapted from (Pearson et al., 2005). 
2. POLYCOMB GROUP PROTEINS 
 
1. History 
The Polycomb (Pc) gene was first identified by Dm genetic screens as a coding 
gene of the bithorax complex repressor (Lewis, 1978). Subsequently, Ian Duncan 
isolated another gene, whose mutation leads to segmental transformation of 
Drosophila. He suggested that this gene product regulates the expression of the 
genes in Antennapedia complex as well as the bithorax complex. Since the mutant 
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phenotype was similar to the one of Polycomb, the newly discovered gene was named 
as Polycomblike (Pcl; Duncan, 1982). Thereafter, a number of scientists identified 
dozens of genes exhibiting similar phenotypes as the Pc. These genes are thus now 
classified as PcG genes (Jürgens, 1985). The PcG genes and the function of their 
encoded proteins are highly conserved in multicellular organisms (Whitcomb et al., 
2007).  
2. PcG proteins form multimeric complexes 
Years later, a number of research groups demonstrated that PcG proteins 
form multimeric complexes by biochemical purifications. In 1998 Harte et al. 
presented that Extra sex combs (Esc) and Enhancer of zeste (E(z)) are directly 
associated in vivo by showing their co-localization in Dm larval polytene 
chromosomes1 (Tie et al., 1998). Then, following the identification of another novel 
PcG gene, suppressor of zeste 12 (Su(z)12; Birve et al., 2001), several research groups 
reported that the E(z) is directly associated not only with Esc but also with Su(z)12 
and Nucleosome-remodelling factor 55 kDa subunit (Nurf55), a histone chaperone. 
This association was shown both in the Drosophila embryo and the mammalian cells 
(Cao et al., 2002; Czermin et al., 2002; Kuzmichev et al., 2002; Müller et al., 2002). 
This complex was called as Polycomb repressive complex-2 (PRC2; Kuzmichev et al., 
2002), named after Polycomb repressive complex-1 (PRC1), which had been purified 
by Kingston and his colleagues in 1999 (Shao et al., 1999). Subsequently, several 
more PcG complexes were purified: Pho repressive complex (Pho-RC; Klymenko, 
2006), RING-associated factor (dRAF; Lagarou et al., 2008) and Polycomb 
repressive deubiquitinase (PR-DUB; Scheuermann et al., 2010) (Figure 5). Besides, 
most recently, a number of PRC1 variants, each including the RING1A/B and distinct 
                                                        
1 Polytene chromosomes are over-sized chromosomes as a result of sister chromatid fusions 
by multiple rounds of DNA replication without cell devision (endomitosis). The polytene 
chromosomes are commonly found in Drosophila salivary glands. 
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PCGF, have been identified in mammals (Gao et al., 2012). The PcG protein 
complexes contain also some non-PcG proteins (e.g. Nurf55, AEBP2, JARID2 and 
KDM2). 
3. PcG proteins modify chromatin 
An inherent feature of all the Polycomb repressive complexes is to bind and 
modify target chromatin. Among these, solely PhoRC has been shown to bind to DNA 
in a sequence-specific manner (Klymenko, 2006). PRC1 and dRAF ubiquitinate 
histone H2A Lys 118, and PRC2 methylates histone H3 Lys 27 (Figure 5). More 
details of the PcG subunits and their human homologues are described in Table 1. 
Among the PcG complexes, PRC2 is discussed further in the section I.2.7 (p. 14). 
 
Figure 5. Schematics of Dm PcG 
complexes 
Key functions of the PcG complexes 
are described below each schematic; 
catalytic subunits to modify chromatin 
are in bold. Subunits drawn distantly 
from the PRC2 represent sub-
stoichiometric subunits of PRC2 
(Jarid2, Jing and Pcl); PRE, Polycomb 
response element; full names of the 
subunits are listed in Table1. 
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Table 1. List of subunits of PcG protein complexes and their functions 
Tables were adapted from (Di Croce and Helin, 2013; Piunti and Shilatifard, 2016). 
Drosophila melanogaster Homo sapience Conserved function
Polycomb repressive complex 1 (PRC1)
RING1B/RNF2
RING1A/RNF1
Posterior sex combs (Psc) PCGF4/BMI1 Enhances E3 Ligase activity of RING,               compacts chromatin
Suppressor of zeste 2 (Su(z)2) PCGF2/MEL18
Polycomb (Pc) CBX2/PC1
CBX4/PC2
CBX6
CBX7
CBX8/PC3
Polyhomeotic-proximal/distal (Ph-P/D) PHC1-3 compacts chromatin
Sexcombs on midleg (SCM) SCMH1-2, SCML2 binds to H3-K9me1 and Sfmbt
Lysine (K)-specific demethylase 2 (Kdm2) KDM2B demethylates H3-K36me3
Polycomb repressive complex 2 (PRC2)
Enhancer of zeste (E(z)) EZH2
EZH1
Supressor of zeste 12 (Su(z)12) SUZ12 required for HMTase activity, binds target chromatin
Extra sexcombs (Esc) EED1-4
Extra sexcombs-like (Escl)
Nucleosome remodeling factor 55 (Nurf55) RBBP7/RBAP46
RBBP4/RBAP48
Polycomblike (Pcl) PHF1/PCL1
MTF2/PCL2
PHF19/PCL3
Jing AEBP2 stimulates H3-K27me3,                                        sub-stiochiometric subunit of PRC2
Jumonji, AT rich interactive domain 2 (JARID2) JARID2 sub-stiochiometric subunit of PRC2
Pho repressive complex (PhoRC)
Pleiohomeotic (Pho) binds to DNA sequence-specifically
Pleiohomeotic-like (Phol) PHO paralog
Scm-like with four MBT domains (Sfmbt) L3MBTL2, MBTD1, hSFMBT1/2 binds to H3-K9me1/2 , H4-K20me1/2
Polycomb repressive deubiquitinase (PR-DUB)
Calypso BAP1 deubiquitylates H2A-K118 (K119) Ub
Anterior sex combs (Asx) ASXL1, ASXL2, ASXL3 activates deubiquitylase activity
dRING-associated factors (dRAF)
Ring/Sexcomb extra (Ring/Sce) E3 Ligase for H2A-K118 (K119) ubiquitylation
Posterior sex comb (Psc) Enhances E3 Ligase activity of RING
Lysine (K)-specific demethylase 2 (Kdm2) KDM2B demethylates H3-K36me3
YY1, YY2
binds to H3-K27me3 for H3-K27me3 propagation,                               
required for HMTase activity
Sex comb extra (Sce/dRING) E3 Ligase for H2A-K118 (K119) ubiquitylation
binds to H3-K27me3 through chromodomain
catalytic subunit of H3-K27 methylation
binds target chromatin
stimulates H3-K27me3,                                        
sub-stiochiometric subunit of PRC2
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4. Polycomb target genes 
Genome-wide chromatin immunoprecipitation (ChIP) on microarray analyses 
performed in Drosophila cultured S2 cells and in mouse/ human embryonic stem 
(ES) cells revealed many novel Polycomb target genes in addition to the Hox genes 
(Boyer et al., 2006; Lee et al., 2006; Oktaba et al., 2008; Schwartz et al., 2006; 
Tolhuis et al., 2006). These newly identified Polycomb target genes include many 
transcriptional and developmental regulators and tumour suppressor genes. 
5. PcG protein recruitment 
In Dm, Polycomb response elements (PREs) have been described as cis-
regulatory elements to recruit PcG proteins (Chan et al., 1994). The PREs span 
several hundreds to a few thousand base pairs in length and can be located upstream 
or downstream of the Polycomb target genes. The PREs contain various conserved 
short consensus motifs of different DNA binding proteins including Pho (Pho-RC 
subunit; Fritsch et al., 1999), GAF and ZESTE (Schwartz and Pirrotta, 2007). One 
recent report showed that the recruitment of PcG proteins to the PRE transgene is 
abolished when Pho consensus sequences are mutated (Frey et al., 2016). 
PRC1 has been reported to interact directly with PhoRC (Mohd-Sarip, 2005; 
Mohd-Sarip et al., 2002). More recently, the Müller group provided structural and 
biochemical evidences of the interaction between two Sterile alpha motif (SAM) 
domains of the Scm (PRC1 subunit) and the Sfmbt (PhoRC subunit; Frey et al., 2016). 
In addition, non-canonical mammalian PRC1 variants were shown to be recruited to 
CpG islands1 by KDM2B, which binds to non-methylated CpG  
                                                        
1 CpG islands: a region with at least 200bp with a GC percentage of at least 60%. Unlike other 
regions in the vertebrate genome, the CpG sites in the CpG islands of promoters are 
unmethylated if the genes are expressed (reviewed in Deaton and Bird, 2011). 
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sequences via its CXXC Zinc finger1 domain (Blackledge et al., 2014; Farcas et al., 
2012).  
However, our understanding of PRC2 recruitment is yet limited. Several research 
groups suggested that the long noncoding (lnc) RNA2 helps PRC2 targeting (reviewed 
in Blackledge et al., 2015). For instance, the Cech group showed that the PRC2 binds 
to the lncRNA promiscuously by gel shift assays, and suggested that this non-specific 
binding of PRC2 to RNA transcripts allows the PRC2 to scan for the target genes 
(Davidovich et al., 2013). In addition, several groups proposed that accessory 
subunits of PRC2 (Pcl, AEBP2 and JARID2) facilitate the PRC2 recruitment. For 
example, the Pcl mutant Dm embryo shows diminished levels of Su(z)12 bound to the 
PREs (Nekrasov et al., 2007). Additionally, PRC2 associated with JARID2 and 
AEBP2 is suggested to be recruited to the ubiquitinated H2A, which is catalysed by 
PRC1 (Blackledge et al., 2014; Cooper et al., 2014; Kalb et al., 2014). Besides, Helin 
and his colleagues proposed that a transcriptionally repressed state itself could be 
responsible for recruiting PRC2 to the CpG islands in mouse embryonic stem (mES) 
cells (Riising et al., 2014).  
6. Structural studies of PcG protein 
Cooperation amongst the PcG subunits and crosstalk between PcG proteins and 
covalently-modified nucleosomes play crucial roles in the PcG enzymatic action. For 
instance, E(z), the catalytic subunit of PRC2, can methylate its target chromatin only 
in the presence of other subunits of PRC2 (Müller et al., 2002). In addition, 
nucleosomes harbouring active marks (e.g. trimethylation on H3 Lys4 (H3K4me3) or 
                                                        
1 CXXC Zinc (ZN) finger: characterized by two CXXC repeats, found in many chromatin-
associated proteins. Some CXXC ZN fingers exhibit non-methylated CpG binding activity 
2 Long noncoding (lnc) RNA: RNA transcript of longer than 100 nucleotides, which does not 
encode proteins 
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on H3K36 (H3K36me3)) inhibit enzymatic activity of the PRC2 (Schmitges et al., 
2011). Thus, elucidating the cooperativity of the PcG subunits and the crosstalk 
between the PcG proteins and the modified nucleosomes has been of particular 
interest in Polycomb research. In order to unravel these, many research groups have 
used structural approaches. 
Regarding PRC1, the Dm Polycomb (Pc) chromodomain structure was first solved 
in the presence of a histone H320-30K27me3 peptide (Fischle, 2003; Min et al., 2003). 
The Pc-H320-30K27me3 co-crystal structure consolidated previous genetic studies, 
which had revealed the crucial role of E(z) in stabilizing Psc/Su(z)2-Pc to the target 
loci via the Pc chromodomain (Platero et al., 1996; Rastelli et al., 1993). In addition, 
Buchwald et al. solved a crystal structure of the PRC1 ubiquitination module, the 
Ring-Ring heterodimeric complex of murine Ring1b and Bmi1, and uncovered that 
the E3 ligase activity of the Ring1b is enhanced by the Bmi1 (Buchwald et al., 2006). 
A number of years later, McGinty et al. provided a crystal structure of a complex 
containing the PRC1 ubiquitination module and human E2 ligase UbcH5c on a 
nucleosome core particle (NCP) (Figure 6B). This structure shows that the Ring1b 
recognizes the NCP by binding to the histone H2A-H2B acidic patch1 via the arginine 
anchor (Figure 6C; McGinty et al., 2014). 
Regarding PRC2, Margueron et al. presented a crystal structure of human EED 
bound to a histone H3 peptide with K27me3 via an aromatic cage, and showed that 
the H3K27me3-bound EED activates PRC2 allosterically (Margueron et al., 2009). In 
addition, Schmitges et al. solved a crystal structure of the Dm Nurf55 bound to the 
histone H3 peptide via an acidic pocket (Figure 6D), and demonstrated that the 
                                                        
1 acidic patch: acidic surface of H2A/H2B in a nucleosome generated by acidic side chains 
such as H2A E61, D90, and E92.  
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Nurf55 compromises binding to methylated H3 peptides (Schmitges et al., 2011). 
Besides, the EED and the Nurf55 structures have been solved together with short 
peptides of the other PRC2 subunits: EZH239-68 (Han et al., 2007) and Su(z)1279-91 
(Schmitges et al., 2011) respectively. Next, using a hybrid approach of negative 
staining electron microscopy (EM) and cross-linking mass spectrometry (MS), the 
Nogales group presented a 21 Å resolution structure of human AEBP2-PRC2 (Figure 
6E), granting an overview of the molecular architecture of the PRC2 (Ciferri et al., 
2012). A few years later, the Liu group solved the first high resolution structure of 
PRC2 multi-subunits, including EZH2-EED-SUZ12 VEFS1 domain (EZH2-EED-
SUZ12VEFS), in Chaetomium thermophilum (Ct) in the presence of a histone H3 
peptide containing a paediatric brain cancer mutation, the H3 Lysine 27 to 
methionine (H3K27M) (Figure 6F; Jiao and Liu, 2015). The crystal structure of the Ct 
EZH2-EED-SUZ12VEFS fits well with the upper half part of the human full-length 
AEBP2-PRC2 EM structure (Figure 6G). Shortly after the Ct EZH2-EED-SUZ12VEFS 
structural report, sub-human PRC2 crystal structures (Hs EZH2-EED-SUZ12VEFS) 
were solved by two groups (Deng et al., 2016; Justin et al., 2016). The Hs EZH2-EED-
SUZ12VEFS structure exhibits high similarity with the Ct EZH2-EED-SUZ12VEFS 
structure. More details of the PRC2 structures are explained in the section I.7.1) (p. 
14). 
 
                                                        
1 VEFS domain: VRN2-EMF2-FIS2-Su(z)12 domain 
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Figure 6. Examples of PcG protein structures 
(A) An aromatic cage of Pc chromodomain binding to H320-30K27me3 (PDBcode: 1PFB). (B) 
PRC1 ubiquitination module onto NCP (PDBcode: 4R8P). (C) An arginine anchor of Ring1B 
binding to the histone H2A-H2B acidic patch. (D) An acidic pocket of Nurf55 binding to the H3 
N-term peptide (PDBcode: 2YBA). (E) EM structure of AEBP2-PRC2, docked on di-
nucleosomes (model); figure taken from (Ciferri et al., 2012). (F) and (G) Ct EZH2-EED-SUZ12VEFS 
structure in surface presentation (F) and in cartoon presentation fitted to the human AEBP2-
PRC2 EM map (G); figures taken from (Jiao and Liu, 2015). 
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7. Polycomb repressive complex 2 
The core subunits of PRC2 consist of E(z), Su(z)12, Esc and Nurf55 in Dm and 
EZH1/2, SUZ12, EED1-4 and RBBP4/7 in Hs (Figure 7; Cao et al., 2002; Czermin et 
al., 2002; Kuzmichev et al., 2002; Müller et al., 2002). In addition to these core 
subunits, some of the early biochemical purification reports have shown the 
association of PRC2 with other proteins such as histone deacetylase HDAC1/2 (Tie et 
al., 2001), Adipocyte enhancer-binding protein 2 (AEBP2; Cao et al., 2002) and Pcl 
(Tie et al., 2003).  Among those, AEBP2 and Pcl are now generally accepted as 
accessory subunits of PRC2 together with Jarid2, which was identified years later 
(Peng et al., 2009). 
 
Figure 7. Dm and Hs PRC2 subunit compositions 
(A) Subunits of Dm PRC2. (B) Subunits of Hs PRC2; two uncharacterized proteins, C17orf96 
and C10orf12 were identified by mass spectrometry from human PRC2 pull-downs 
(Alekseyenko et al., 2014; Smits et al., 2012). Their counterparts in Dm are not present (or not 
identified yet). 
1) Histone methyltransferase 
The early reports of PRC2 purification presented the enzymatic function of the 
complex: the site-specific methyltransferase activity on histone H3K27 (Cao et al., 
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2002; Czermin et al., 2002; Kuzmichev et al., 2002; Müller et al., 2002) as well as 
H3K9 in vitro in some reports (Czermin et al., 2002, Kuzmichev et al., 2002). The 
Reinberg group suggested that PRC2 methylates histone H1K26 depending on which 
isoform of EED protein is integrated into the complex (Kuzmichev et al., 2004). 
However, many subsequent works have demonstrated that the H3K27 tri-
methylation is the critical function of PRC2 in Polycomb repression (Simon and 
Kingston, 2009). Notably, the cells harbouring a specific point mutation of Lysine 27 
of histone H3 to Arginine (H3K27R) in Dm phenocopy the PRC2 mutant, 
misexpressing some Polycomb target genes (Pengelly et al., 2013).  
i. Contribution of different PRC2 subunits to the H3K27 
methylation  
E(z) mono-, di- and tri-methylates Lysine 27 of histone H3 as a catalytic 
subunit of PRC2 (Ebert et al., 2004; Müller et al., 2002). However, without other 
PRC2 core subunits, the enzymatic activity of E(z) has been shown to be reduced at 
least a 1000-fold by in vitro histone methyltransferase (HMTase) assays (Müller et 
al., 2002). Several extensive biochemical reports have demonstrated that the Esc and 
the Su(z)12 are essential for the HMTase activity, whereas the Nurf55 and the Su(z)12 
are required for nucleosome binding (Ketel et al., 2005; Nekrasov et al., 2005; Pasini 
et al., 2004). Specifically, the Simon group reported that the Su(z)12 VEFS domain is 
the minimal requirement for the HMTase activity of PRC2 in vitro. They also mapped 
a region that stimulates the HMTase activity and a section that interacts to the E(z) in 
the VEFS domain (Rai et al., 2013). In addition, they suggested that the Su(z)12 Zinc 
finger (ZnF) domain is required for PRC2 targeting to the PREs by ChIP experiments 
in Drosophila S2 cells. 
A recently reported crystal structure of the Ct sub-PRC2 (Jiao and Liu, 2015) 
visualized the previous biochemical characterizations at the atomic details (Figure 
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8B). This structural analysis revealed that the catalytic domain of the EZH2 is 
bipartite, composed of both SET1 and SAL2 domains. The SET and SAL domains are 
remotely located in the primary amino acid sequence of EZH2 (Figure 8A), but the 
two domains are brought together in the tertiary structure, stabilized by the EED and 
the SUZ12 VEFS domain to maintain the active conformation of EZH2 (Figure 8C).  
 
Figure 8. Crystal structure of Ct EZH2-EED-SUZ12VEFS 
(A) Domain architecture of Ct EZH2. (B) Overall crystal structure of Ct EZH2-EED-SUZ12 VEFS in 
cartoon representation. (C) Zoomed view of interaction amongst Ct EZH2 (SAL-SET), SUZ12VEFS 
and EED in surface representation. Figures were adapted from (Jiao and Liu, 2015). 
 
                                                        
1 SET domain: su(var)3-9, enhancer-of-zeste and trithorax domain 
2 SAL domain: SET activation loop domain 
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ii. Regulation of histone methyltransferase activity of PRC2 
A steady-state kinetic parameter analysis showed that the turnover number 
(kcat )1 for PRC2 of the H3K27me2 substrate is about ten times lower than that of the 
H3K27me0 or H3K27me1 (Sneeringer et al., 2010). In addition, the crystal structure 
of the Ct PRC2 implies that the substrate binding channel in the EZH2 confers a 
spatial restriction to the H3K27me2 (Jiao and Liu, 2015). In other words, converting 
the H3K27me2 to H3K27me3 by PRC2 is not catalytically favourable.  
 In order to generate the H3K27me3 efficiently, therefore, the PRC2 requires 
other factors. For example, accessory subunits of PRC2, such as PCL, AEBP2 and 
JARID2, enhance the catalytic efficiency of PRC2 (Cao et al., 2008; Herz et al., 2012; 
Kalb et al., 2014; Li et al., 2010; Nekrasov et al., 2007; Peng et al., 2009; Sarma et al., 
2008).  In addition, a recent biochemical report showed that PRC2 is activated in 
dense chromatin environments, presumably by sensing unmodified histone H3 tails 
spanning the residues from 31 to 42 (Yuan et al., 2012). Besides, the Reinberg group 
demonstrated that EED binding to K27me3 on histone H3 tails in trans promotes the 
enzymatic activity of PRC2, and proposed that the H3K27me3 is propagated by this 
(Margueron et al., 2009). Furthermore, the Ct PRC2 crystal structure shows that not 
only the EED but also the SRM2 domain in EZH2 binds to the H3K27me3 peptide. 
Moreover, the structure shows that the EZH2 SRM domain mediates the crosstalk 
between the H3K27me3 peptide and the SET domain of EZH2 to stimulate the 
catalysis (Jiao and Liu, 2015). 
 
                                                        
1 kcat: turnover number, the maximum number of chemical conversions of substrate molecules 
per second that each catalytic site will execute for a given enzyme concentration 
2 SRM domain: stimulation-responsive motif domain 
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Figure 9. Crosstalk between the H3K27me3 
peptide and the SET domain through the SRM 
domain 
H3 peptide in magenta represents the stimulating 
peptide (H3K27me3) bound to the EED; yellow, the 
substrate peptide (H3K27M) bound to the SET 
domain, figure was taken from the (Jiao and Liu, 
2015). 
On the other hand, PRC2 is inhibited by active histone marks such as 
H3K4me3 and H3K36me3 in cis. As briefly mentioned in the section I. 2. 6 (p. 10), 
the Nurf55 binds to the histone H31-11 via its acidic pocket, where any methylation on  
Lys 4 in the H31-11 repulses the stable binding to the Nurf55 (Figure 6D). Although 
that report did not provide the detailed mechanism concerning how the H3K36me3 
peptide regulates PRC2, the report showed that the nucleosomes possessing either 
H3K4me3 or H3K36me3 decrease the HMTase activity of PRC2 (Schmitges et al., 
2011). 
iii. Distribution of H3K27 methylations and PcG proteins 
Mass spectrometry analysis of the methylated status of the H3K27 in wild-
type Dm larval nuclear extracts revealed that around 50 % of the H3K27 is 
dimethylated, whereas only 10 % is trimethylated (Ebert et al., 2004). Another more 
recent genome-wide ChIP sequencing (ChIP-seq) experiment performed in mES cells 
demonstrated that 72 % of the H3K27 residue is modified to the H3K27me2, whereas 
only 7 % is to the H3K27me3 (Ferrari et al., 2013). 
In addition, a number of ChIP experiments have provided insights about the 
distribution of H3K27me3 and PcG proteins in Polycomb target genes (Gutiérrez et 
al., 2012; Papp and Muller, 2006; Schwartz et al., 2006; Tolhuis et al., 2006). For 
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instance, H3K27me3 is shown to form broad domains beyond the localization of PcG 
proteins, shown by ChIP-chip analysis in Dm S2 cultured cells. Interestingly, the 
distribution of the Pc (the reader of H3K27me3) is broader than the one of E(z) (the 
writer of H3K27me3) (Schwartz et al., 2006).  
Besides, the Müller group performed ChIP-quantitative PCR experiments in 
the Polycomb target gene (Ubx) region using two distinct Dm larval tissues: wing 
imaginal discs1, where the Ubx gene is transcriptionally inactive; haltere/3rd leg 
imaginal discs, where the Ubx is active. They demonstrated that the repressive 
marks, such as H3K27me3, H3K9me3 and H4K20me3, decorate the upstream 
control region of Ubx in both tissues, whilst the repressive marks demarcate the 
promoter and 5’-coding regions solely in the wing disc tissue. Moreover, they 
presented that the PcG and TrxG proteins (except for the Ash1 protein) are localized 
to the PRE regions in both tissues (Papp and Muller, 2006).  
2) PRC2 and cancer 
As mentioned in the section I. 2. 4 (p. 9), Polycomb targets include tumour 
suppressor genes. Thus, up-regulation of PRC2 function is closely linked to 
malignant tumours. The PRC2 function can be up-regulated by (i) overexpression of 
PcG genes owing to intergenic or intronic mutations (Vogelstein et al., 2013) or (ii) 
hyperactive PcG proteins due to missense mutations, such as EZH2Y641F/N (Table 2; 
Sneeringer et al., 2010). Specifically, the PRC2 with EZH2Y641F/N favours H3K27me2 
as the substrate, leading to elevation of H3K27me3 (Sneeringer et al., 2010).  
                                                        
1 imaginal disc: one of the parts of a holometabolous insect larva that will become a portion of 
the outside of the adult insect during the pupal transformation. 
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However, interestingly, loss of function mutations of PRC2 have also been 
reported in many cancer cases, exhibiting reduction of H3K27me3 (Conway et al., 
2015). In addition, recent sequencing analysis of paediatric glioma samples revealed 
the somatic mutations of K27M in HIST1H3B and H3F3A, coding genes of the 
histone H3.1 and the histone H3.3, respectively (Table 2; Schwartzentruber et al., 
2012; Wu et al., 2012). A subsequent systematic study demonstrated that the 
H3K27M mutation specifically inhibits the enzymatic activity of PRC2 through 
interaction with EZH2, causing remarkable reduction of H3K27me2 and H3K27me3 
(Lewis et al., 2013). 
The Bracken group proposed that both up- and down-regulation of PRC2 function 
would affect redistribution of H3K27me3 in the genome: increasing the levels of 
H3K27me3 in differentiation-associated genes and decreasing the H3K27me3 in 
cancer-associated genes (Conway et al., 2015).  
 
Table 2. Mutations 
of PRC2 and histone 
H3 coding gene in 
different cancer 
types 
MDS, myelodysplastic 
syndrome; MPNST, 
malignant peripheral 
nerve sheath tumours, 
the table was adapted 
from (Conway et al., 
2015). 
Gene Aberration Cancer type
H3K27 methylation 
status
PRC2 mutations
EZH2 Y641X 
Lymphoma, parathyroid 
adenoma, melanoma
elevated H3K27me3, 
reduced H3K27me2 
A677G Lymphoma, Ewing sarcoma
elevated H3K27me3, 
reduced H3K27me2 
A687V Lymphoma
elevated H3K27me3, 
reduced H3K27me2 
Homozygous mutation Leukemia, myeloid disorders reduced H3K27me3
Heterozygous Leukemia, myeloid disorders reduced H3K27me3
SUZ12 mutation MDS/MPN, leukemia, MPNST reduced H3K27me3
Heterozygous deletion MPNST reduced H3K27me3
Heterozygous deletion/ mutation MPNST reduced H3K27me3
Homozygous deletion MPNST reduced H3K27me3
EED Heterozygous deletion/ mutation MPNST reduced H3K27me3
Heterozygous deletion MPNST reduced H3K27me3
Homozygous deletion MPNST reduced H3K27me3
Histone H3 mutations 
H3F3A K27M mutation 
High grade glioma,                     
low grade glioma, leukemia
reduced H3K27me3, 
reduced H3K27me2
HIST1H3B K27M mutation High grade glioma
reduced H3K27me3, 
reduced H3K27me2
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8. Polycomblike 
Pcl is one of the earliest isolated PcG genes in Drosophila (Duncan, 1982). The 
Pcl-/- Drosophila dies as of the mature embryo stage and shows the posteriorly 
directed homeotic transformation (e.g. the abdominal segment 7 (A7) is transformed 
to the A8, and the A6 to the A7; Figure 10). The transformation phenotype is more 
severe in the Pcl-/- Dm embryo lacking maternally-loaded Pcl protein (Pclmaternal-zygotic-, 
Pclm-z-) than in the Pcl-/- Dm embryo having the maternally-deposited Pcl protein 
(Pclm+z-) (Breen and Duncan, 1986).  
 
Figure 10. Posteriorly directed homeotic transformation in Pcl mutant embryonic 
cuticles 
Ventral cuticle of (A) a wild-type (Canton-S) first instar larva, (B) a Pclm+z- embryo and (C) a Pclm-z- 
embryo. Arrows indicate transformation of embryonic segments; abbreviations: A2-A8: 
Abdominal segment 1-8; figures were adapted from (Breen and Duncan, 1986). 
Mammalian homologues of Pcl consist of three different paralogues: PHD 
finger protein 1 (PHF1/Phf1), Metal-response element-binding transcription factor 2 
(MTF2/Mtf2) and PHD finger protein 19 (PHF19/Phf19) (Table 1; Figure 11). The Pcl 
homologues share conserved domain architectures including the Tudor domain and 
the Plant homeodomains (PHD1 and PHD2) (Figure 11).  The Phf1 and the Mtf2 were 
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first studied in different contexts than the Polycomb repression: spermatogenesis 
(Ha et al., 1991) and Zn-dependent metallothionein promoter binding (Inouye et al., 
1994; Remondelli and Leone, 1997), respectively. Later, bioinformatic analyses 
identified that these proteins are the mammalian homologues of the Dm Pcl (Coulson 
et al., 1998). 
 
Figure 11. Domain architecture of Pcl homologues 
Upper numbers indicate the amino acid residue numbers; abbreviations: WH, winged-helix; C, 
C-terminal domain. 
1) Pcl is associated with PRC2 
The Jones group first reported the association of Pcl with the Esc-E(z) 
complex in the Dm embryo nuclear extracts, showing co-migration of the three 
proteins on the gel filtration (O'Connell, 2001). Later, the Müller group showed that 
the Pcl forms a stable complex with the PRC2 core subunits by a tandem affinity 
purification (TAP) strategy. They presented that the TAP-tagged Pcl were eluted with 
substantial amounts of PRC2 core subunits, whereas the TAP-tagged E(z) with much 
less amounts of Pcl, indicating that the Pcl is a sub-stoichiometric subunit of PRC2 
(Nekrasov et al., 2007).  
The Jones group suggested that the Pcl PHD1 and PHD2 mediate the 
interaction with E(z) by yeast two-hybrid assays. Furthermore, they presented that 
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this PHD finger mediating interaction is conserved in the human PHF1 with the 
EZH2 (O'Connell, 2001). However, the Brockdorff group showed that the Mtf2 
constructs lacking the Tudor domain, the PHD1, or the PHD2 still form a stable 
complex with EZH2 by co-immunoprecipitation (co-IP) (Casanova et al., 2011). In 
addition, the Di Croce group showed that the C-terminal domain of Phf19 is essential 
to interact with the SUZ12 by co-IP (Ballaré et al., 2012). 
2) Pcl is required for PRC2 to generate H3K27me3 efficiently 
A few years after the first report of association of the Pcl with PRC2 
(O'Connell et al., 2001; Tie et al., 2003), several groups showed that Pcl/PHF1 helps 
PRC2 generate high levels of H3K27me3 by in vitro HMTase assays (Cao et al., 2008; 
Nekrasov et al., 2007; Sarma et al., 2008). In addition, the levels of H3K27me3 are 
reduced in Polycomb target genes in Pcl-/- Dm embryos (Nekrasov et al., 2007) or 
Phf1-knock down mouse male germ cells (GC1Spg) (Cao et al., 2008), shown by ChIP 
experiments. Moreover, antibody staining experiments showed that a subset of 
Polycomb target genes are misexpressed in the Pcl-/- Dm embryo (Nekrasov et al., 
2007), indicating that the efficient H3K27me3 by Pcl-PRC2 is crucial for Polycomb 
repression.  
3) Pcl facilitates PRC2 recruitment 
Another reported function of the Pcl is to facilitate PRC2 recruitment to target 
genes (Cao et al., 2008; Nekrasov et al., 2007; Sarma et al., 2008; Casanova et al., 
2011; Ballaré et al., 2012; Brien et al., 2012a; Hunkapiller et al., 2012). Upon down-
regulation of Pcl/Phf1, the levels of the Su(z)12/Suz12 (PRC2 subunit) enrichment on 
Polycomb target genes are reduced, whereas the levels of Pho (Pho-RC subunit) or Ph 
(PRC1 subunit) are unaffected, shown by ChIP analyses in Dm embryos and GC1spg-
derived Phf1-knockdown cells (Cao et al., 2008; Nekrasov et al., 2007). In addition, 
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the Brockdorff group showed that the PRC2 recruitment is reduced in Mtf2-
knockdown mES cells by ChIP experiments. This group also demonstrated that Ezh2 
recruitment to the inactive X chromosome loci is impaired upon down-regulation of 
the Mtf2 in the 3-day differentiated XX mES cell by immuno-RNA fluorescent in situ 
hybridisation (FISH) analysis (Casanova et al., 2011). Besides, several articles 
presented that the bindings of SUZ12 and EZH2 to a subset of target genes in mES 
cells are diminished upon Phf19 knockdown (Ballaré et al., 2012; Brien et al., 2012a; 
Hunkapiller et al., 2012). Of note, the Di Croce group performed the vice versa 
experiment. They showed that Phf19 binding to Polycomb target genes is almost 
entirely abolished in Eed-/- mES cells (Ballaré et al., 2012), indicating that the Phf19 
requires the intact PRC2 to bind to Polycomb target genes.  
Whereas many studies have suggested the role of Pcl in helping PRC2 
recruitment as mentioned above, one report proposed that the Pcl is the actual 
recruiter of PRC2. This report showed that the binding of the E(z) to a PRE region is 
completely abolished in Pcl-knockdown Dm larval wing discs (Savla et al., 2008).  
4) Mammalian Pcl proteins bind to H3K36me3 via Tudor domains 
A number of research groups showed that mammalian PCL proteins (i.e. Phf1, 
Mtf2 and Phf19) bind to the H3K36me3, whose mark is found in the actively 
transcribed chromatin (Kouzarides, 2007), via an aromatic cage in their Tudor 
domains (Ballaré et al., 2012; Brien et al., 2012a; Cai et al., 2013; Musselman et al., 
2012). Remarkably, the Dm Pcl lacks the aromatic cage in the Tudor domain to bind 
to the methylated histone tails (Friberg et al., 2010). 
The binding of Phf19 to the H3K36me3 is suggested to play a crucial role in the 
lineage transition in mES cells, which changes the transcription status of the actively 
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transcribed genes to the repressed status. To be specific, the Phf19 is suggested to 
recruit the histone demethylase of H3K36me3 to the loci, which allows PRC2 to 
methylate the H3K27 in turn (Ballaré et al., 2012; Brien et al., 2012; Cai et al., 2013). 
Similarly, the Wang group proposed that the PHF1 tudor domain recruits the 
PRC2 to the actively transcribed genes and increases the levels of H3K27me3 in the 
HeLa cell (Cai et al., 2013). However, the Kutateladze group suggested that the 
binding of PHF1 Tudor domain to the H3K36me3 sterically hinders PRC2 to bind the 
target chromatin, and that this inhibits the H3K27 methylation by PRC2 in the HeLa 
cell (Musselman et al., 2012).  
5) PHF1-specific roles 
The Phf1 is highly expressed in testis (Kawakami et al., 1998) and quiescent cells 
(Brien et al., 2015), whereas the Mtf2 and the Phf19 are highly expressed in 
embryonic stem cells (Walker et al., 2010; Hunkapiller et al., 2012). Accordingly, the 
MTF2/Mtf2 and the PHF19/Phf19 seem to have some shared roles, e.g. regulation of 
stem cell renewal and differentiation (Ballaré et al., 2012; Brien et al., 2012a; 
Hunkapiller et al., 2012; Walker et al., 2010), whilst the PHF1/Phf1 seems to have 
distinctive roles.  
Firstly, the PHF1 has been suggested to be recruited to the double-stranded-DNA 
(ds-DNA) break sites, shown by co-IP with the Ku70/Ku80 in the HeLa cell (Hong et 
al., 2008). A few years later, the Kutateladze group showed that PHF1 recruitment to 
the ds-DNA break sites is the Tudor domain dependent (Musselman et al., 2012). 
Secondly, the PHF1 has been proposed to stabilize the p53, a tumour suppressor, 
in quiescent cells (Brien et al., 2015). The turnover of p53 is regulated by MDM2-
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mediated ubiquitination. Yang et al. showed that the PHF1 binds to the C-terminus of 
p53 and this binding protects the p53 from the MDM2-mediated ubiquitination and 
degradation (Yang et al., 2013). Interestingly, the Bracken group showed that the 
expression of PHF1 gene is regulated by the p53 in the quiescent cell (Brien et al., 
2015).   
3. AIM AND SCOPE 
As described in previous sections, the key function of the Pcl homologues in PRC2, 
promotion of H3K27 trimethylation by PRC2, is crucial for the Polycomb repression 
in both Dm and mammals (Cao et al., 2008; Nekrasov et al., 2007; Sarma et al., 
2008). However, our understanding of the molecular mechanism of this has 
remained elusive. Thus, I attempted to shed light on the molecular roles of the Pcl in 
PRC2 (i) by solving the crystal structure of the previously uncharacterized PHD and 
WH domain in the Pcl, (ii) by demonstrating the DNA binding activity of the 
Pcl/PHF1 WH domain using biophysical assays, (iii) by mapping the PRC2 binding 
domain in the PHF1, (iv) by determining the DNA and nucleosome binding activities 
of various PRC2 complexes (e.g., PRC2, PHF1-PRC2, PHF1WH(E)-PRC2) and (v) by 
comparing histone methyltransferase activities of the various PRC2 complexes in 
vitro. 
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II. MATERIALS AND METHODS 
1. MATERIALS 
 
Table 3. List of cell strains used in this study 
 
Table 4. List of plasmids used in this study 
The numbers in the second column indicate the residue numbers of the constructs. When no 
number is described in the second column, the constructs encode full-length protein. 
Abbreviations: Clea., cleavage site; Res., antibiotics resistance; Kan., Kanamycin; Amp., 
Ampicillin. 
Strain Organism Source
Top 10 F´ Escherichia coli Invitrogen
BL21-CodonPlus-RIL Escherichia coli Agilent
DH10EMBacY Escherichia coli Geneva Biotech
IPLB-Sf21 (Sf21) Spodoptera frugiperda Invitrogen
BTI-TN-5B1-4 (High Five) Trichoplusia ni Invitrogen
Number Protein name_constructs Vector Affinity tag Clea. Res. Species Specifications Source
JC10 Pcl_491-694 pEC-K-3C-His 6xHis 3C Kan. Dm this study
JC17 Pcl_419-694 pEC-K-3C-His 6xHis 3C Kan. Dm this study
JC14 Pcl_491-694 pEC-K-3C-His 6xHis 3C Kan. Dm K650A,R651A this study
JC15 Pcl_491-694 pEC-K-3C-His 6xHis 3C Kan. Dm R631A,Q634A,K637A this study
JC16 Pcl_491-694 pEC-K-3C-His 6xHis 3C Kan. Dm Q634A,K637A, K650A,R651A,R631A this study
JC20 Pcl_511-694 pEC-K-3C-His 6xHis 3C Kan. Dm this study
JC28 PHF1_165-363 pEC-K-3C-His 6xHis 3C Kan. Hs this study
JC35 PHF1_165-363 pEC-K-3C-His 6xHis 3C Kan. Hs K323A, K324A this study
JC212 PHF1 pFastBac 2xStrepII-6xHis TEV Amp. Hs this study
JC227 PHF1_WH(A) pFastBac 2xStrepII-6xHis TEV Amp. Hs K323A, K324A, R304A, S307A, N310A this study
JC228 PHF1_WH(E) pFastBac 2xStrepII-6xHis TEV Amp. Hs K323E, K324E, R304E, S307E, N310E this study
JC269 PHF1(TEV@432) pFastBac 2xStrepII-6xHis TEV Amp. Hs TEV site insertion @ 432 this study
JC232 PHF1_28-end pFastBac 2xStrepII-6xHis TEV Amp. Hs this study
JC233 PHF1_1-363 pFastBac 2xStrepII-6xHis TEV Amp. Hs this study
JC234 PHF1_28-363 pFastBac 2xStrepII-6xHis TEV Amp. Hs this study
JC238 PHF1_del(364-510) pFastBac 2xStrepII-6xHis TEV Amp. Hs this study
JC257 PHF1_515-end pFastBac 2xStrepII-6xHis TEV Amp. Hs this study
JC297 PHF1_186-end pFastBac 2xStrepII-6xHis TEV Amp. Hs this study
JC213 PHF19 pFastBac 2xStrepII-6xHis TEV Amp. Hs this study
JC241 PHF19_38-end pFastBac 2xStrepII-6xHis TEV Amp. Hs this study
JC242 PHF19_1-375 pFastBac 2xStrepII-6xHis TEV Amp. Hs this study
JC243 PHF19_38-375 pFastBac 2xStrepII-6xHis TEV Amp. Hs this study
JC244 PHF19_del(378-529) pFastBac 2xStrepII-6xHis TEV Amp. Hs this study
JC258 PHF19_529-end pFastBac 2xStrepII-6xHis TEV Amp. Hs this study
EZH2 EZH2 pFastBac 6xHis TEV Amp. Hs C.Müller lab
JC235 EZH2 pFastBac 2xStrepII-6xHis TEV Amp. Hs this study
JC303 EZH2_107-129_259-end pFastBac 6xHis TEV Amp. Hs this study
JC304 EZH2_107-160_259-end pFastBac 6xHis TEV Amp. Hs this study
SUZ12 SUZ12 pFastBac 6xHis TEV Amp. Hs C.Müller lab
JC286 SUZ12_71-end pFastBac 6xHis TEV Amp. Hs this study
EED EED pFastBac 6xHis TEV Amp. Hs C.Müller lab
RBBP4 RBBP4 pFastBac 6xHis TEV Amp. Hs C.Müller lab
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Table 5. List of fluorescein (Flc)-labelled oligo nucleotides used in the DNA binding 
assays 
 
Table 6. List of oligo nucleotides used for PCR amplification of the nucleosomal 601 
DNA  
 
Table 7. List of antibodies used in this study 
 
Table 8. List of growth media used in this study 
name DNA sequence (Forward, 5´-3´)
30bp DNA TCCCTCTCTCCGCAGTCGCGGCGCAGTCGC
PRE01 CGTGCGTAAGAGCGAGATAC
PRE02 AGCGAGATACAGATAAGACT
PRE03 AGATAAGACTACGCGCACCA
PRE04 ACGCGCACCATAATGGCTGC
PRE05 TAATGGCTGCGCCGTAAAGC
PRE06 GCCGTAAAGCGAGAGCGATC
PRE07 GAGAGCGATCCGAGCGAGAA
PRE08 CGAGCGAGAAGGCTAACCGT
PRE09 GGCTAACCGTATCTCTCCCT
PRE10 ATCTCTCCCTCTCTCCGCAG
PRE11 CTCTCCGCAGTCGCGGCGCA
PRE12 TCGCGGCGCAGTCGCTGCCT
PRE13 GTCGCTGCCTCTGCAGCTCC
PRE14 CTGCAGCTCCGTCGCCATAA
PRE15 GTCGCCATAACTGTCGTTCG
PRE16 CTGTCGTTCGTAATGGCCGT
PRE17 TAATGGCCGTTTTAAGTGCG
PRE18 TTTAAGTGCGACTGAGATGG
PRE19 ACTGAGATGGCCTCATAATC
PRE20 CCTCATAATCGTTTGCTGAA
PRE21 GTTTGCTGAATCTGAATGGT
Number Name DNA sequence (Forward, 5´-3´)
YN 281 601_215_Fwd ATATCTCGGGCTTATGTGATGGAC
YN 282 601_215_Rev ATATCCCGAGTCGCTGTTCAATAC
DB 85 601_215_Fwd-flc flc-ATATCTCGGGCTTATGTGATGGAC
YN 285 601_147_Fwd CTGGAGAATCCCGGTGCC
YN 286 601_147_Rev ACAGGATGTATATATCTGACACGTGCC
DB 87 601_147_Fwd-flc flc-CTGGAGAATCCCGGTGCC
Antibody Dilutions Host Source
H3K27me1 1:6000 rabbit Milipore (07-448)
H3K27me3 1:1000 rabbit Milipore (07-449)
H4 1:200000 rabbit Abcam (ab 10156)
Pcl (PHD-WH) 1:3000 rabbit this study
Nurf55 1:50000 rabbit C. Müller lab
HRP 1:5000 donkey GE Healthcare (NA934)
Media Application Description Source
L-Broth (LB) cloning with E.coli - In-house
Terrific broth (TB) expression with E.coli supplemented with 10% Phosphate buffer In-house
SOC cloning with E.coli - In-house
TiterHigh virus generation with Sf21 cells - Sigma
Express Five protein expression with High five cells supplemented with L-Glutamine Gibco
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Table 9. List of general buffers used in this study 
 
2. METHODS 
1. General methods 
1) Molecular cloning 
i. Polymerase Chain Reaction (PCR) 
 10-30 ng template DNA, 0.2 µmol forward and reverse primers (Table 5 and 
Table 6), and Phusion polymerase 2 x master mix (Finnzymes) were used in a 50 µl 
reaction volume with a PCR program described in Table 10. Mutagenesis PCR was 
performed with the same procedure but with a 10 min extension time.  
 
Table 10. PCR program 
 A part of the PCR products were loaded to 0.8 to 1.5 % agarose gel (pre-
stained with 10000 x GelRed Nucleic acid gel stain, Biotium) to check the specificity 
of the PCR reaction. Once the specificity was confirmed by a single band in the 
agarose gel, all the PCR products were treated with DpnI (NEB) at 37 °C for 1 hr to 
Name Composition Application
Phosphate buffer 0.17M KH2PO4, 0.72M K2HPO4H2O supplement for TB media
Phosphate-buffered saline (PBS) 10mM Na2HPO4, 1.8mM KH2PO4, 137mMNaCl, 2.7mM KCl insect cell harvest, TBS
20X TBE 1M Tris, 0.89M Boric acid, 20mM EDTA pH 8.0 agarose gel electrophoresis (used in 0.4X)
10X Lämmli 0.25M Tris, 1.92M Glycine, 1% SDS acrylamide gel electrophoresis (used in 1X)
1X transfer buffer 25mM Tris, 192mM Glycine, 0.05% SDS, 10% Methanol wet transfer
TBS PBS, 0.2% Tween 20 western blot
Step Temperature Time (min) No. of cycles
1 98 °C 5 1
2 98 °C 0.5
3 72 °C 0.5 per kb template DNA
4 72 °C 5 1
25 (repeat the step 2-3)
 
30 
digest the template DNA. The reaction was then purified using the QIAquick PCR 
purification kit (Qiagen). 
ii. Restriction digestion and ligation 
 A classical restriction enzyme based cloning strategy was used to generate 
clones with the pFastBac vectors. The purified PCR products and the pFastBac 
vectors were digested with appropriate enzymes in their corresponding reaction 
buffers (Buffer 1 to 4; NEB) for 1 hr at 37 °C.  Subsequently, pFastBac vectors were 
incubated with Calf intestinal alkaline phosphatase (CIP, NEB) to prevent the self-
ligation. The digestion reactions of both inserts and vectors were purified by using 
the QIAquick PCR purification kit (Qiagen). A molar ratio of 3: 1 insert to vector was 
used for ligation in 20 µl reaction volumes using the Quick ligation kit (NEB).  
iii. Ligation independent cloning (LIC) 
 The LIC system was used to generate clones with the pEC-K-3C-His vectors (a 
kind gift from the Elena Conti lab). The LIC system uses the T4 DNA polymerase (T4 
DNA pol, Novagen), which cleaves the nucleotides until the T4 DNA pol reaches a 
Thymine (T) by the 3’ to 5’ exonuclease activity. By incubating the vectors with the T4 
DNA pol and dTTP and the inserts with the T4 DNA pol and dATP, 12 to 15 bp 
overhang sequences are generated. The inserts and vectors are annealed with the 12 
to 15 bp overhangs. Nicks are then repaired during transformation in E.coli. 
 All components added for processing of the vectors and inserts are listed in 
Table 11. The mixture was incubated at room temperature for 30 min, and 
subsequently at 75 °C for 20 min to inactivate the enzyme. For annealing, 1 µl of the 
vector processing reaction and 2 µl of the insert processing reaction were incubated 
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at room temperature for 10 min, and subsequently 1 µl 25 mM EDTA was added at 
room temperature for 10 min.  
 
Table 11. LIC reaction mix for the vector (left) and the insert (right) 
ddH2O, double-distilled water 
iv. Vector transformation 
2- 5 µl DNA (ligated DNA, mixture of LIC reactions, or mutagenesis PCR 
product) were added to 50 µl chemically competent cells (Top10F’, Invitrogen, Table 
3) and incubated on ice for 30 min. Then the cells were transformed by heat shock at 
42 °C for 45 sec and subsequent rest on ice for 10min. Next, the cells were recovered 
in 900µl LB medium at 37 °C for 45 min to 1 hr with shaking at 600 rpm. The cells 
were then spun down at 5500 rpm for 2min. The cell pellet was resuspended in 100 
µl LB medium and spread onto an LB-Agar plate containing the appropriate 
antibiotic. The plate was incubated overnight at 37 °C. 
v. Verification of clones 
 On the next day of the transformation, two to three colonies were picked and 
grown in separate tubes with LB medium supplemented with the respective 
antibiotics. Simultaneously, PCR was performed with picked colonies (colony PCR) to 
verify insertion of the gene of interest. On the following day, plasmids of the colonies 
which had been verified by the colony PCR were isolated with the Miniprep 
Components amount Components amount
Linearised vector 450 ng Purified PCR product 600 ng
T4 DNA Pol. buffer (10X) 3 µl T4 DNA Pol. buffer (10X) 2 µl
dTTP (25mM) 3 µl dATP (25mM) 2 µl
DTT (100mM) 1.5 µl DTT (100mM) 1 µl
T4 DNA Pol. LIC qualified 0.6 µl T4 DNA Pol. LIC qualified 0.4 µl
ddH2O to 30 µl ddH2O to 20 µl
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purification kit (Qiagen) and sent for DNA sequencing (core facility, Max Planck 
Institute of Biochemistry). Sequences were analysed by using SeqManPro (Lasergene 
12). 
2) SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) of proteins 
Samples were heated in the 4 x Lithium dodecyl sulphate (LDS) sample buffer 
(Invitrogen) supplemented with 400 mM Dithiothreitol (DTT) at 70 °C for 5min. 
Samples were loaded onto self-casted 12-13 % (for PRC2 complexes) or 15 % (for Pcl 
constructs) SDS-polyacrylamide gels. Histone methyltransferase reactions were 
heated at 95 °C for 5 min and loaded onto the NuPAGE Novex 4- 12 % Bis-Tris 
gradient gels (Invitrogen). Electrophoresis was run in 150 V for 50 min to 90 min. 
3) Coomassie Brilliant Blue staining 
First of all, the SDS-PAGE gels were rinsed with the double-distilled water 
(ddH2O) for 5 min three times. Then the gels were incubated with the PageBlue 
protein staining solution (Thermo Scientific) for 30 min with gentle agitation. 
Finally, the gels were destained with ddH2O for 10 min with gentle agitation.  
2. Specific methods used in this study 
1) Protein sequence alignment 
Protein sequence alignment was performed using Clustal omega (Sievers et al., 
2011), and figures were prepared by Jalview2 (Waterhouse et al., 2009). 
2) Secondary structure prediction 
Secondary structure prediction was performed on the PSIPRED server (Buchan 
et al., 2013). 
 
33 
3) Generation of Pcl constructs 
The genes encoding Dm Pcl amino acid (a.a.) residue 419-694, 491-694, 511-
694 and Hs PHF1 a.a. 165-363 were subcloned into the pEC-LIC-3C-His vector, 
containing a hexa-histidine tag and a 3C protease cleavage site at the N-terminus. 
Mutant constructs were cloned by site-directed mutagenesis based on the Quick-
Change protocol (Stratagene).   
4) Protein expression of Pcl constructs using bacterial system 
50 - 100 ng plasmids were used to transform BL21 codon plus (DE3) RIL cells 
(Agilent, Table 3). Next morning, the colonies were picked and cultured in 50 - 
100 ml TB medium (Table 8) at 37 °C, 225 rpm for 4 to 5 hrs. The pre-cultures were 
then inoculated into 500 ml TB medium supplemented with phosphate buffer (Table 
8) and selective antibiotics in tune air flasks (2.5 L in volume), and incubated at 
37 °C, 225 rpm. Usually 6-12 flasks (3 to 6L TB medium in total) were used for large-
scale expression to produce 20-40 mg purified protein. When the optical density at 
600 nm (OD600) of the cell suspension was 0.6, the temperature setting was switched 
to 18 °C. Around 2 hrs later, when the incubator was at 18 °C, 0.4 mM Isopropyl β-D-
1-thiogalactopyranoside (IPTG) was added to the culture to induce the protein 
expression. Usually the OD600 was between 1.2 and 1.5 at this point. The cultures 
were then incubated overnight (16-18 hrs) at 18 °C, 225 rpm. Next morning the 
induced cells were harvested by spin-down at 5500 rpm for 15 min in the JA-16 rotor 
in a centrifuge (Avanti J-26XP, Beckman Coulter). The pellets were resuspended with 
buffer A (20 mM Tris-HCl (pH8.0 at 4 °C) 150 mM NaCl 1 mM 4-(2-Aminoethyl) 
benzenesulfonyl fluoride hydrochloride (AEBSF) and either used directly for 
purification or stored at -80 °C after flash freezing with liquid nitrogen. 
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5) Purification of Pcl constructs 
Bacterial cell suspension was lysed by Emulsiflex c-3 (Avestin) and the lysates 
were centrifuged for 1 hr at 4 °C, 21500 rpm. Subsequently, the supernatants were 
loaded onto Ni-Nitrilotriacetic acid (NTA) resin (Qiagen) by gravity flow. Unspecific 
proteins were washed with buffer B (20 mM Tris-HCl (pH8.0 at 4 °C) 1 M NaCl) and 
buffer A supplemented with 40 mM Imidazole. Then desired proteins were eluted 
with buffer A supplemented with 250 mM imidazole. The eluents were diluted twice 
with 20 mM Tris-HCl (pH8.0 at 4 °C) 4 mM DTT, and hexa-His tag was cleaved with 
3C protease overnight at 4 °C. Next day, the tag-free proteins were loaded onto three 
pre-packed 1 ml HiTrap Heparin HP columns (GE Healthcare) connected in series 
and eluted by gradient of buffer A and buffer B with 2 mM DTT. The eluent did not 
contain any contaminant bands shown by SDS-PAGE analysis. The eluents 
subsequently were loaded onto Superdex75/10/300 column equilibrated with 20 mM 
Tris-HCl (pH8.0 at 4 °C) 150 mM NaCl. Purity of all purified protein constructs was 
confirmed by total MS. 
6) Limited proteolysis 
Pcl419-694 was incubated with 0.05 mg/ml Trypsin (Sigma) for 45 min and the 
reaction was stopped by adding AEBSF. The digested protein fragments were 
separated by Superdex75 (GE Healthcare), equilibrated with 20 mM Tris-HCl (pH8.0 
at 4 °C) 150 mM NaCl. Eluted fractions were analysed by total MS, N-term 
sequencing and SDS-PAGE.   
7) Crystallization  
1 µl Pcl491-694 (10 mg/ml) was mixed with 0.5 µl reservoir (12.5 % polyethylene 
glycol (PEG) 3350, 50 mM Potassium Phosphate (dibasic) and 2 mM Manganese 
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Chloride). 1 µl Pcl511-694 (3.4 mg/ml) was mixed with 0.5 µl reservoir (22.5 % PEG 
6000, 50 mM Potassium Phosphate (dibasic) and 3 mM Manganese Chloride). Both 
crystals were grown by hanging drop vapour diffusion method at 20 °C. Crystals were 
flash frozen in the presence of cryo-protectant, 25 % (v/v, in final) ethylene glycol. 
8) Data collection and structure determination 
Anomalous and native data sets were collected for the Pcl491-694 crystal with a 
PILATUS 6M detector using the Swiss Light Source (SLS) PXI beam line. Phases 
were calculated by the single wavelength anomalous dispersion (SAD) method at the 
zinc peak using Phenix-Autosol (Terwilliger et al., 2009). Native data sets were 
collected for the Pcl511-694 crystal with a PILATUS 6M detector using the SLS PXII 
beam line. The Pcl511-694 structure was solved by molecular replacement with Phenix-
AutoMR (Adams et al., 2010) using the Pcl491-694 structure as a search model. In both 
cases, I used the program package XDS (Kabsch, 2010) for data processing, Phenix-
refine (Afonine et al., 2012) for refinement and COOT (Emsley and Cowtan, 2004) 
for building atomic models. All structural figures were prepared with PyMol (ver.1.8, 
Schrödinger) and the superpositions were performed by using COOT SSM superpose 
(Emsley and Cowtan, 2004). 
9) Generation of PHF1 constructs 
 Human PHF1 cDNA (codon optimized for S.frugiperda, GenScript) was 
subcloned into pFastBac vector with two consecutive strep-II tags, a hexa-histidine 
tag and a Tobacco Etch Virus (TEV) protease-cleavable site in the N-terminus. PHF1 
point mutants (PHF1WH(A) and PHF1WH(E)) were cloned by site-directed mutagenesis 
based on the Quick-Change protocol (Stratagene). The pFastBac plasmids containing 
cDNA of human PRC2 core subunits with N-terminal hexa-histidine tags were a kind 
gift from Christopher Müller lab (Kalb et al., 2014). 
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10) Protein expression of various PRC2 complexes using baculoviral 
system 
i. General insect cell culture  
Sf21 cells (Invitrogen, Cat no.12682-019, Table 3) were cultured in EX-
CELL®TitherHigh™ medium (Sigma, Table 8) and used for transfection and virus 
amplification. High Five cells (Invitrogen, P/N 51-4005, Table 3) were cultured in 
ExpressFive medium (gibco, Table 8) supplemented with 18 mM L-Glutamine 
(Gibco, Table 8) and used for protein expression. Both cell lines were maintained as 
500 mL suspension culture in 3L Erlenmeyer flasks (Corning) with appropriate cell 
density (0.7-1 x 106 cells/ml for Sf21 cells; 0.4-0.8 x 106 cells/ml for High Five cells), 
and kept until approximately passage 30. Cell density, diameter and viability were 
monitored with a Vi-cell XR cell viability analyzer (Beckman coulter). 
ii. Transformation of DH10EMBacY  
100-200 ng pFastBac vectors containing the genes of interest were 
transformed into 100 µl DH10EMBacY (Geneva Biotech, Table 3) cells. All 
transformation procedures were the same as those for bacterial transformation, 
except that cells were recovered in SOC medium for 4 hrs after heat shock. The 
recovered cells were spun down at 1500 x g for 4 min and resuspended in 200 µl LB.  
The suspension was spread onto two LB plates supplemented with antibiotics  
(50 µg/ml Kanamycin, 10 µg/ml Tetracycline, 7 µg/ml Gentamicin, 34 µg/ml 
Chloramphenicol, 100 µg/ml Blue-gal, 40 µg/ml IPTG): one with 20 µl and the other 
with 160 µl. Then the plates were incubated in 37 °C for 48 hrs. The positive colonies, 
which gene of the interest is transposed from the pFastBac vector to the bacmid, were 
distinguished by their white colours. True white colonies were picked for mini-
culture in 2.5 ml LB (with 50 µg/ml Kanamycin, 10 µg/ml Tetracycline, 7 µg/ml 
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Gentamicin, 34 µg/ml Chloramphenicol) for 24 hrs at 37 °C, and re-streaked on a 
new LB plate (with 50 µg/ml Kanamycin, 10 µg/ml Tetracycline, 7 µg/ml Gentamicin, 
34 µg/ml Chloramphenicol, 100 µg/ml Blue-gal, 40 µg/ml IPTG) to confirm their 
white colour. 
iii. Bacmid purification 
Confirmed bacmids were purified by alkaline lysis from the mini cultures. First, 
mini cultures were spun down at 19000 x g for 3 min. Then the pellets were 
resuspended in 300 µl P1 (resuspension buffer with RNase, QIAGEN). Subsequently, 
300 µl P2 (alkaline lysis buffer, QIAGEN) and 300 µl N3 (neutralization buffer, 
QIAGEN) were added, and the suspension was mixed. Next, the lysates were spun 
down at 19,000 x g for 10 min at 4 °C. The supernatants were transferred to sterile 
2 ml Eppendorf tubes, and centrifuged at 19,000 x g for 5 min at 4 °C. The 
supernatants were then transferred to sterile 2 ml-Eppendorf tubes and incubated 
with 800 µl isopropanol for 10 min on ice. Next, the samples were centrifuged at 
19,000 x g for 20 min at 4 °C. Subsequently, the pellets were washed with 500 µl 
70 % ethanol, and spun down at 19,000 x g for 10 min at room temperature. The 
pellets were air-dried at 37 °C. Finally, the pellets were resuspended in 100 µl sterile 
ddH2O. 
iv. Transfection of Sf21 cells 
Firstly, 2 ml 0.4 x 106 cells/ml Sf21 cell suspension were incubated in each well of 
a 6-well tissue culture (TC) plate (BD Falcon) for 30-60 min at 27 °C. Then, 
transfection was performed using the purified bacmid and transfecting reagents, 
cellfectin II (Invitrogen), including negative controls (transfecting reagents only). 
After 4 hrs of incubation with the transfecting agents, all liquid in the wells was 
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removed and 2 ml fresh TiterHigh medium was added to the each well. Then the TC 
plates were sealed with parafilm and incubated at 27 °C for 72 hrs. Then the 
supernatants were collected: passage 1 (P1) virus. 
v. Virus amplification 
50 ml 0.4 x 106 cells/ml Sf21 cells were infected with 2ml harvested P1 viruses, 
and the infected cells were cultured at 27 °C, 90 rpm. The cell density was inspected 
every 24 hrs, and duplicated cells (cell density of more than 1.0 x 106 cells/ml) were 
diluted with fresh medium to below 1.0 x 106 cells/ml. 48 hrs after the cells stopped 
proliferating, passage 2 (P2) viruses were harvested by centrifugation at 2000 rpm 
for 15 min. Then 2.5 ml P2 viruses were infected to 250 ml 0.4 x 106 cells/ml Sf21 
cells, and the cells were cultured for in suspension. 72 hrs after the P2 infection, the 
supernatant (P3 viruses) were harvested. The P2 and P3 viruses were kept at 4 °C 
(protected from the light). Subsequently, various amounts of P3 viruses were used to 
infect 3 ml High Five cells at a density of 0.4 x 106 cells/ml in order to test the titre.  
vi. Protein expression 
In this study, the High Five cells were co-infected by four to five single viruses. 
Thus, prior to expression, a number of small-scale expression tests were performed 
to determine the optimal ratio of the mixture of the different P3 viruses. In order to 
obtain 10-40 mg purified PRC2 complexes, 4 to 8 L High Five cells (0.8 x 106 
cells/ml) were infected with the optimal ratio of each virus. The infected cells were 
cultured for 50-72 hrs and harvested by centrifugation at 2000 rpm for 15 min. The 
pellets were resuspended in PBS and spun down for 15 min at 2000 rpm to wash the 
residual growth medium. Pellets were frozen with liquid nitrogen or used directly for 
protein purification. 
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11) Purification of various PRC2 complexes 
The harvested cells were then lysed by a glass homogenizer in a lysis buffer (50 
mM Phosphate-sodium pH8.0, 150 mM NaCl, 20 mM Imidazole, 4 % glycerol, 2.5 
mM MgCl2, 0.05 % Nonidet-P40 (NP40), 1 mM Dithiothreitol (DTT), 1 mM AEBSF 
and cOmplete EDTA free protease inhibitor cocktail tablets (Roche)). The cleared 
lysates were loaded onto Ni-NTA resin (Qiagen) by gravity flow. The unspecific 
proteins were washed with a wash buffer (50mM Phosphate-sodium pH8.0, 500 mM 
NaCl, 50 mM imidazole and 4 % glycerol), and the desired proteins were eluted with 
a His-elution buffer (50mM Phosphate-sodium pH8.0, 150 mM NaCl, 250 mM 
imidazole and 4 % glycerol). The eluents were subsequently loaded onto strep tactin 
sepharose (IBA) and eluted with a strep-elution buffer (25 mM HEPES pH7.9, 150 
mM NaCl and 10 mM Desthiobiotin (Sigma)). SDS-PAGE analysis showed that the 
complexes are highly pure and stoichiometric after this purification step. The 
complexes were then incubated with TEV protease (Core facility of Max Planck 
Institute of Biochemistry) and Lambda protein phosphatase (Core facility of Max 
Plnack Institute of Biochemistry) overnight at 4 °C. The tag-free protein complexes 
were purified over MonoQ resins by salt gradient in 25 mM HEPES pH7.9, and 
finally polished by Superose6 resins (GE healthcare) equilibrated with a buffer 
containing 25 mM HEPES pH7.9 and 100 mM NaCl. Purity of all purified protein 
constructs was confirmed by using total MS.  
12) Preparation of Flc-labelled DNA  
 Various 5’-Flc-labelled single stranded oligos (Table 5) and their 
complementary non-labelled oligos (Sigma) were mixed with their complementary 
non-labelled oligos (Sigma) and incubated for 10 min at 80 °C. The mixture was then 
slowly cooled down for annealing. The annealed oligos were verified by 18 % TBE 
acrylamide gel electrophoresis.  
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 Flc-labelled 147 bp 601 DNA (Lowary and Widom, 1998) was generated by 
PCR using the 5’ Flc-labelled forward primer and the non-labelled reverse primer 
(Table 6) to reconstitute Flc-labelled nucleosomes used in native gel shift assays. 
13) Nucleosome reconstitution 
The 147 bp and 215 bp DNA harbouring 601 sequences (Lowary and Widom, 
1998) were amplified by PCR using corresponding primer sets (Table 6) and purified 
over a 1 ml HiTrapQ column (GE Healthcare) by salt gradient in 25 mM HEPES pH 
7.9. The amplified 601 DNA (either 147 bp or 215 bp) was eluted around a 
conductivity of 67 % (around 700 mM NaCl; Figure 12A). The purity was verified by 
1.2 % agarose gel electrophoresis (Figure 12A) and concentrated up to 1 to 2 mg/ml 
by ethanol precipitation. Histone octamer refolding (Figure 12B) and nucleosome 
reconstitution (Figure 12C) were performed as described previously (Luger et al., 
1999). After the reconstitution, the absence of uncoupled DNA of the reconstituted 
nucleosome was verified by 1.2 % native agarose gel electrophoresis (Figure 12C). 
14) Fluorescence Polarization (FP) 
 45 nM 30bp Flc-labelled ds DNA oligos were incubated with increasing 
amounts of proteins in a buffer C (25 mM HEPES-NaOH pH7.9, 50 mM NaCl, 0.05 
% tween-20, 5 mM MgCl2 and 4 % Glycerol) for 5 min at 20 °C. The fluorescence was 
measured by a Synergy H1 plate reader (excitation wavelength at 485 nm and 
emission at 528 nm; BioTek), and the polarization was monitored by Gen5 2.05 
software. All measurements were performed in triplicates. Hill function fitting and 
graphical representation of the triplicate measurements were carried out using Origin 
9.0 software (OriginLab, Northampton, MA). 
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Figure 12. Nucleosome reconstitution 
(A) Top: HiTrapQ elution profile of 601 DNA PCR products; Bottom: a 1.2 % agarose gel 
containing the input (IN), flow-through (F.T.) and the eluents (1-4) of the HiTrapQ purification.  
(B) Top: a gel filtration profile of refolded histone octamer on Superdex200 increase;  
Bottom: a 14 % polyacrylamide-SDS gel containing the eluents of the gel filtration.  
(C) A 1.2 % native agarose gel containing reconstituted nucleosomes (Nuc147). 
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15) Microscale thermophoresis (MST) 
45 nM 30bp Flc-labelled ds-DNA oligos were incubated with increasing amounts 
of proteins in the buffer C for 5 min on ice. The samples were loaded into standard 
capillaries for the DNA binding measurements. Thermophoresis was measured with 
30 % LED and 50 % MST power by a Monolith NT.115 (Nanotemper). All 
measurements were performed in triplicates. Hill function fitting and graphical 
representation of the triplicate measurements were carried out using Origin 9.0 
software (OriginLab, Northampton, MA).   
16) Native gel shift assay 
45 nM Flc-labelled oligos and nucleosomes were incubated with increasing 
amounts of proteins in buffer C for 5 min on ice. 10 µl of the sample were loaded into 
1.2 % agarose (Seakem) gel. Gel electrophoresis was performed with cold 0.4 x TBE 
buffer (4°C) at 60 V for 45 min. Fluorescence signals were acquired by a Typhoon 
FLA 9500 (GE Healthcare) using the Cy2 filter. Each native gel analysis presented 
here was performed in triplicates. Densitometry was performed with Fiji software 
(Schindelin et al., 2012). Hill function fitting and graphical representation were 
carried out using Origin 9.0 software (OriginLab, Northampton, MA). 
17) Histone methyltransferase (HMTase) assay 
Indicated amounts of various versions of PRC2 complexes were incubated with 
446 nM mononucleosomes in a reaction buffer (20 mM HEPES pH7.4, 50 mM NaCl, 
2.5 mM MgCl2, 5 % glycerol, 0.25 mM EDTA, 0.5 mM DTT and 80 µM  
S-adenosylmethionine (SAM)) in a total volume of 15 µl at 25 °C for indicated 
durations. 4 x LDS sample buffer (Invitrogen) supplemented with 400 mM 
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Dithiothreitol (DTT) was added to the reaction and immediately heated at 95 °C for 5 
min to terminate the methylation activity. 
18) Western blotting of histone methyltransferase reaction samples 
The histone methyltransferase reactions were run on a poly-acylamide SDS gel, 
and then transferred to membranes (Amersham Hybond ECL Nitrocellulose Blotting 
Membrane, 0.22 µM, GE Healthcare) by wet transfer.  
Prior to wet transfer, three Whatman papers (Chromatography paper, 3 mm, 
Whatman) and one membrane (Amersham Hybond ECL Nitrocellulose Blotting 
Membrane, 0.22 µM, GE Healthcare) per each polyacrylamide-SDS gel were 
equilibrated with 1 x transfer buffer (Table 9). Then, a “sandwich” was prepared as 
follows: one thick sponge, one Whatman paper, the polyacrylamide-SDS gel, the 
membrane, two Whatman papers, and one thin sponge. The cassette was then 
inserted to a transfer tank filled with 1 x transfer buffer, with the gel facing on the 
cathode side and the membrane on the anode side. Wet transfer was performed  
at 90 V for 10 min and at 60 V for 30 min at 4 °C under mild agitation. Membranes 
were blocked with TBS supplemented with 4 % BSA (w/v) (4 % BSA TBS; Table 9) at 
4 °C for overnight. Next day, the membranes were washed with TBS three times and 
then incubated with H3K27me3 antibody (milipore, Table 7) diluted in 4 % BSA TBS 
at 4 °C for 8 hrs. Next, H4 antibody (milipore, Table 7) was added to the membrane 
and incubated further for 2 hrs at room temperature. Next day, the membrane was 
washed with TBS three times and incubated with horseradish peroxidase (HRP) 
conjugated secondary antibody for 1 hr. Finally, the membrane was washed three 
times with TBS and covered with 1:1 mixture of detection reagent A and B (ECL 
Select, Amersham). The chemiluminescence was detected by an ImageQuant 
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LAS4000 (GE Healthcare). Densitometry of the western blot was carried out with Fiji 
software (Schindelin et al., 2012). 
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III. RESULTS 
1. STRUCTURAL AND FUNCTIONAL ANALYSIS OF PCLP H D 2-W H 
1. Purification and limited proteolysis of Pcl419-694 
In order to obtain molecular insights into Pcl function in promoting H3K27 
methylation by PRC2, I pursued to solve the crystal structure of conserved domains 
in Pcl. First, I designed a construct spanning from the PHD1 to a conserved domain 
next to the PHD2 (Pcl419-694; Figure 13A). I sub-cloned the Pcl419-694 to a vector 
containing N-terminal hexa-histidine tag cleavable by 3C protease. The Pcl419-694 was 
expressed in E.coli and purified over Ni-NTA, Heparin and Superdex 75 resins 
(Figure 13B). The final gel filtration profile and SDS-PAGE gel analysis demonstrated 
the homogeneity and high purity of the Pcl419-694 (Figure 13C). I tried to crystallize the 
purified Pcl419-694 in myriads of different crystallizing conditions, but the construct 
was not crystallized.  
Thus, I went on to perform limited proteolysis with the purified Pcl419-694 to obtain 
more crystallizable construct. After a number of screenings using different proteases, 
I found that the Pcl419-694 is cleaved into two pieces upon treatment with 0.05 mg/ml 
trypsin, where the two fragments do not interact with one another (Figure 14A and 
B). Then total MS and N-term sequencing analyses revealed that the Pcl419-694 is 
cleaved between the two PHD fingers (Figure 14C). Hence, I designed a new 
construct containing the PHD2 and the conserved domain next to the PHD2, which 
spans a.a. 491 to 694 (Pcl491-694; Figure 15A). 
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Figure 13. Purification of Pcl419-694 construct 
(A) Domain composition of Pcl419-694 construct. (B) Purification scheme. (C) Top: a gel filtration 
profile; A280, absorption at 280 nm; A260, absorption at 260 nm; bottom: SDS-PAGE analysis 
of the eluents. 
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Figure 14. Limited proteolysis of Pcl419-694 construct 
(A) A gel filtration profile (Superdex 75) of tryptic digested Pcl419-694. (B) SDS-PAGE analysis of the 
input (IN, tryptic digested Pcl419-694) and the eluents of peak1 and peak2 of the gel filtration in (A). 
Peak 3 and 4 did not contain any protein (data not shown). (C) Schematics showing where 
trypsin digests the Pcl419-694 construct. 
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2. Purification and crystallization of Pcl491-694 
I cloned the proteolytically stable construct (Pcl491-694; Figure 15A) into the same 
vector as the one used for Pcl419-694, and followed the same purification procedure. 
Final gel filtration profile and the SDS-PAGE analysis demonstrated that the purified 
Pcl491-694 is highly homogenous and pure (Figure 15B and C).  
 
Figure 15. Purification of Pcl491-694 construct 
(A) Domain composition of Pcl491-694. (B) A gel filtration profile of Pcl491-694 on Superdex 75. (C) 
SDS-PAGE analysis of the eluents of gel filtration in (B). 
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 With the purified Pcl491-694, I obtained several crystals in a number of 
conditions containing PEG 3350 in neutral pH. The initial crystals were small in size  
(Figure 16A), so I attempted to optimize the crystallization by adjusting the 
precipitant concentrations and adding various additives. I was then able to obtain a 
single crystal in a reasonably large size (Figure 16B). The optimized Pcl491-694 crystal 
was flash frozen with a cryo-protectant, 25 % ethylene glycol, and mounted (Figure 
16C). The optimized Pcl491-694 crystal resulted in a diffraction data set with a 
resolution limit of 2.5 Å (Figure 16D and Table 12). 
 
Figure 16. Crystallization of Pcl491-694 construct 
(A) Initial crystal of Pcl491-694 in a 96 well plate, sitting-drop (0.2 μl protein + 0.1 μl reservoir). (B) 
Optimized crystal of Pcl491-694 in a 24 well linbro plate, hanging-drop (1 μl protein + 0.5 μl 
reservoir). (C) Mounted Pcl491-694 crystal in a nylon-loop (left) and its 90° rotation (right); red oval, 
beam focus. (D) A screen shot showing the diffraction of the Pcl491-694 crystal. 
 
*The sections below includes contents from the manuscript prepared for publication. 
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3. Overall structure of PCLPHD2-WH 
 The Pcl491-694 crystal structure was solved by Zn-single wavelength anomalous 
dispersion (SAD) method (Figure 17 and Table 12). Notably, the Pcl491-694 crystal 
structure shows that the conserved domain next to the PHD2 possesses a canonical 
WH domain fold (Figure 17A), in agreement with bioinformatic predictions 
(Callebaut and Mornon, 2012; Söding, 2005). The PHD2 and the WH domain 
stabilize each other by extensive van der Waals and electrostatic contacts along the 
interface, especially the loop regions between βB and βC, and between β2 and α5  
(Figure 17B and C).  
  
Table 12. Data collection and refinement statistics of Pcl419-694 and Pcl491-694 crystal 
[1] Highest resolution shell shown in parentheses. 
 
Construct Pcl511-694
Data set native Peak (Zn) native
Wavelength (Å) 1.00005 1.28344 0.97935
Space group C 1 2 1 C 1 2 1 P 1 21 1
a, b, c (Å) 307.42 53.12 86.84 307.42 53.12 86.84 94.2, 50.57, 95.51
α, β, γ (°) 90 105.47 90 90 105.47 90 90, 113.1, 90
83.69  - 2.45 83.69  - 2.45 79.15  - 2.3
(2.53  - 2.45) (2.59  - 2.50) (2.27  - 2.19)
R-merge 0.045 (0.64) 0.11 (1.33) 0.08 (1.31)
CC1/2 0.997 (0.828) 0.998 (0.696) 0.999 (0.552)
CC* 0.999 (0.952) 1 (0.906) 1 (0.844)
Mean I/sigma(I) 17.09 (2.25) 14.27 (1.39) 12.00 (0.87)
Completeness (%) 98.65 (98.18) 98.06 (91.36) 98.61 (86.43)
Multiplicity 3.4 (3.4) 6.6 (6.6) 6.6 (4.8)
No. Molecule per A.U. 6 6 4
83.69  - 2.447 79.15  - 2.3
(2.534  - 2.447) (2.266  - 2.188)
Total reflections 167531 (16931) 280326 (17801)
Unique reflections 49847 (4912) 42581 (3688)
R-work 0.2365 (0.3483) 0.2303 (0.4329)
R-free 0.2780 (0.3708) 0.2680 (0.4483)
No. of non-hydrogen atoms 9076 5756
Wilson B-factor 59.74 54.25
RMS(bonds) 0.016 0.004
RMS(angles) 1.41 0.89
Ramachandran favored (%) 98 98
Ramachandran outliers (%) 0 0
Average B-factor 77.1 67
Resolution (Å)
Pcl491-694
Data collection
Resolution (Å)[1]
Refinement
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Figure 17. Crystal structure of PclPHD2-WH 
(A) A ribbon view of the overall Pcl491-694 crystal structure; PHD2 is coloured slate; WH domain 
coloured orange; two Zn atoms are represented by spheres and coloured light pink; Zn-
coordinating residues in stick representation; secondary structure elements (α: alpha-helix and 
β: beta-sheet), wing (w), N-terminus (N) and C-terminus (C) of the constructs are labelled.  
(B) Sequence alignment of PHD2-WH domains in Dm and Hs Pcl proteins; secondary structural 
elements based on Pcl491-694 crystal structure are described; the numbers on the left- and right 
ends indicate a.a. residue numbers; blue boxes, Zn-coordinating residues; blue asterisks, 
residues composing an aromatic cage; blue or orange circles, residues involved in the 
interaction between PHD2 and WH domain; orange reversed triangles, residues mutated for 
DNA binding assays (Figure 19). (C) An expanded view of the interface between the PHD and 
WH domain; salt bridges in dotted lines. 
4.  Pcl PHD2 contains a closed aromatic cage  
The Pcl PHD2 possesses seven Cys and one His that coordinate two Zinc ions 
(Figure 17A; reviewed in Sanchez and Zhou, 2011). Some PHD finger domains form 
an aromatic cage, which binds to covalently modified histone peptides such as di- or 
tri-methylated lysine 4 of histone H3 (H3K4me2/3; Wang et al., 2010). The PclPHD2-
WH structure shows that the Pcl PHD2 forms an aromatic cage with conserved 
residues: Phe523, Met527 and Trp536 (Figure 18A and B), the latter corresponding to 
the highly conserved Trp that forms the sidewall of the cage in most PHD finger 
domains (Sanchez and Zhou, 2011). However, the Pcl PHD2 aromatic cage is closed 
by the phenyl-ring of the Phe523 residue (Figure 18B), in contrast to the wide-open 
cage of MLL1 PHD3 in the absence of its ligand (Figure 18C).  
In order to abolish the possibility of crystallization artefacts, I purified and 
crystallized Pcl511-694 construct, which still possesses the PHD2 and the WH domain 
but lacks the extra loop region in the N-terminus of the Pcl491-694 construct. The Pcl511-
694 was indeed crystallized in a different space group (P1 21 1) to Pcl491-694 (C 1 2 1; 
Table 12). However, the aromatic cage of Pcl511-694 is still blocked by the phenyl-ring of 
the Phe523, whereas the loop region of the Pcl511-694 PHD2 is deviated from the one of 
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Pcl491-694 (Figure 18D). In addition, the Pcl constructs do not show any binding to a 
variety of methylated histone peptides in solution binding assays (data not shown). 
Thus, this structural analyses show that the Pcl PHD2 aromatic cage is closed in the 
Pcl constructs. Hereafter, all represented structures are the crystal structure of  
Pcl491-694, and I call the Pcl491-694 as PclPHD2-WH.  
 
Figure 18. A closed aromatic cage in Pcl PHD2 
(A) Sequence alignment of the Pcl PHD2 and the MLL1 PHD3. (B) Expanded view of the Pcl419-
694 PHD2 aromatic cage. (C) Structural superposition of the Pcl419-694 (in slate) onto the MLL1  
(in grey; PDB code: 3LQH) PHD aromatic cage. (D) Structural superposition of the Pcl419-694 (in 
slate) onto the Pcl491-694 (in light blue) PHD aromatic cage. 
5. Pcl binds to DNA via the conserved WH domain in a sequence 
non-specific manner 
 WH domains are found in many nucleic acid binding proteins. Although the 
WH domains retain the overall conserved fold, the DNA recognition modes are 
diverse (Harami et al., 2013). For example, canonical WH domains such as the one 
found in FOXO1 recognize their consensus DNA sequence by binding to the DNA 
major groove via the α3, referred as the recognition helix (Brent et al., 2008). On the 
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other hand, some other non-canonical WH domains such as the one found in hRFX1 
contact mainly DNA phosphate backbones (Gajiwala et al., 2000). In addition, 
depending on their binding profiles, the detailed structural folds of WH domains vary 
(Harami et al., 2013).    
 In order to examine the role of Pcl WH domain in DNA binding, I first 
superimposed the PclPHD2-WH structure onto a crystal structure of the FOXO1 WH 
domain that was solved together with its consensus DNA sequences (Brent et al., 
2008). This structural comparison proposed that Arg631, Gln634 and Lys637 of the 
α3 region in the Pcl WH domain might engage in binding to the DNA major groove, 
and Lys650 and Arg651 of the w1 region to the DNA phosphate backbone contacts 
(Figure 19A, PDBcode: 3CO6). I next generated and purified three different PclPHD2-
WH proteins harbouring point mutations on these residues: PclPHD2-WHR631A/Q634A/K637A 
(α3mut), PclPHD2-WHK650A/R651A (w1mut) and PclPHD2-WHR631A/Q634A/K637A/K650A/R651A (α3-w1 
mut; Figure 19A and B).  I then measured the DNA binding activities of the wild-type 
PclPHD2-WH and the point mutants by using FP assays. The wild-type PclPHD2-WH binds 
to the DNA probe (Flc-labelled 30 bp-long ds DNA) with a dissociation constant (Kd)1 
of 9.7 µM, whilst the α3 mut and the w1 mut compromise the binding (Figure 19C). 
Moreover, the α3-w1 mut causes even further reduction in DNA binding activity of 
PclPHD2-WH (Figure 19C). This DNA binding activity via the WH domain is conserved 
in human PHF1PHD2-WH as determined by FP assays (Figure 19D). 
  
                                                        
1 Dissociation constant, Kd: a specific type of equilibrium contant that measures the 
propensity of a larger object to dissociate reversibly into smaller components. The Kd has a 
dimensions of concentration. In case of event that molecule A and B binds reversibly (AxBy ⇌ 
xA + yB), and the Kd equals the concentration of a free A at which half of the total B are 
associated with A.  
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Figure 19. DNA binding activity of the Pcl WH domain 
(A) Structural superposition of the PclPHD2-WH (in slate and orange) onto the FOXO1 WH domain-
DBE (in grey; PDB code: 3CO6). (B) Coomassie staining of a 15 % polyacrylamide-SDS gel 
containing wild-type (wt) and point mutant (α3 mut, w1 mut and α3-w1 mut) PclPHD2-WH proteins. 
(C, D and F) Quantitative measurement of DNA binding of PclPHD2-WH (C and F) or PHF1PHD2-WH (D) 
by FP; dots represent the mean values of the triplicate measurements; error bars, standard 
deviation of the triplicates; curve fitting was preformed by Hill function; Kd in parenthesis. (E) 
Schematics of bxd PRE DNA sequences used in FP measurements shown in (F); six lollipops on 
bxd PRE box represent Pho binding sites. (F) Quantitative measurement of PclPHD2-WH binding to 
PRE probes. 
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 Pcl has been proposed to facilitate the PRC2 recruitment (Ballaré et al., 2012; 
Brien et al., 2012b; Casanova et al., 2011; Nekrasov et al., 2007; Savla et al., 2008). I 
thus questioned whether the Pcl binds DNA in a sequence-specific manner. To test 
this, I generated a set of Flc-labelled 20 bp-long ds DNA probes spanning a 200 bp 
interval that forms the core bxd Polycomb response element (PRE), where the PcG 
proteins are specifically localised in Drosophila (Papp and Muller, 2006; Figure 19E). 
I then compared the binding affinities of PclPHD2-WH to these different PRE probes by 
using FP assays. I observed that the PclPHD2-WH possesses comparable affinities to all 
the PRE probes with the Kd of between 2.9 and 13.3 µM (Figure 19F), indicating that 
the PclPHD2-WH binds to the bxd PRE in a sequence non-specific manner. In line with 
this, the solvent exposed residues in α3 are only poorly conserved among the Pcl 
homologues (Figure 17B). Together, these results show that the Pcl binds to DNA via 
the conserved WH domain in a sequence non-specific manner. 
2. FUNCTIONAL ANALYSIS OF PHF1-PRC2 
1. Purification of PHF1-PRC2 
Given the structural and biophysical evidence of Pcl/PHF1 in DNA binding via the 
conserved WH domain, I next asked about which role the Pcl/PHF1 WH domain 
would play in the context of a full-length Pcl/PHF1-PRC2 complex. To do this, I 
attempted to purify homogeneous and stoichiometric recombinant PHF1-PRC2 
complex. By the previous reports, purifying homogenous Pcl/PHF1-PRC2 seems to 
be challenging (Cao et al., 2008; Nekrasov et al., 2007; Sarma et al., 2008). First 
trials to express PHF1-PRC2 in HiFive cells using the DH10Bac strain as the bacmid 
donor cell showed that the PHF1 protein was degraded in the cells (data not shown). I 
then tested the expression using a new strain, DH10EMBacY, which the v-cath gene 
that encodes a viral cathepsin-type cysteine protease (V-CATH) is deleted in the 
baculoviral genome. The deletion of v-cath has been reported to improve protein  
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Figure 20. Purification of PHF1-PRC2 
(A) Coomassie staining of a 15 % polyacrylamide-SDS gel containing the High Five cell lysates 
expressing PHF1-PRC2. (B) Purification scheme. (C) Coomassie staining of a 4-12 % gradient 
polyacrylamide-SDS gel containing eluents from each purification step. (D) A gel filtration profile 
of PHF1-PRC2 on a Superose 6 column. (E) Coomassie staining of a 12 % polyacrylamide-SDS 
gel containing eluents from the gel filtration. 
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expression through reducing virus-dependent proteolytic activity (Berger et al., 
2004). Using the DH10EMBacY as the bacmid donor cell enabled me to express 
stable PHF1-PRC2 complex in insect cells (Figure 20A). I then purified the PHF1-
PRC2 with a series of chromatography (Figure 20B and C). Since PHF1 showed lots 
of phosphorylation, I treated the PHF1-PRC2 eluents with lambda protein 
phosphatase (LPP). Final gel filtration profile and its corresponding SDS-PAGE 
analysis verified the homogeneity of the stoichiometric PHF1-PRC2 (Figure 20D and 
E).  
2. PHF1 C-terminal domain is essential for PHF1 to form a stable 
complex with PRC2 
 Next, I attempted to map the PRC2 interacting domain(s) in the PHF1. To do 
this, I generated a number of different constructs of PHF1 (Figure 21A) harbouring a 
strep tag in the N-terminus, and coexpressed each of them with his-tagged PRC2. I 
then performed strep-pull down experiments, and discerned the interaction profile of 
the different PHF1 constructs to PRC2 by SDS-PAGE analysis (Figure 21B). 
 First of all, the construct without the N-terminal part of PHF1 (PHF1ΔN; 
Figure 21A) is unstable; no intact PHF1ΔN was eluted from the purification (Figure 
21B lane 1). Secondly, the constructs without the C-terminal part (PHF1ΔC and 
PHF1ΔNΔC; Figure 21A) are stable, but do not interact with PRC2 (Figure 21B lane 2 
and 3). Thirdly, the construct spanning from the PHD2 to the C-terminus (PHF1 
(PHD2-C); Figure 21A) forms a complex with PRC2 (Figure 21B lane 4), but the 
construct is highly unstable indicated by the degradation of the PHF1 (PHD2-C) upon 
the strep-tag cleavage (data not shown). Finally, either having only the conserved C-
terminal domain of PHF1 (PHF1(C); Figure 21A) or deleting the loop region between 
the WH and the C-terminal domains (PHF1Δloop; Figure 21A) gives rise to the stable 
association of the PHF1 constructs with PRC2 (Figure 21B lane 5 and 6).  
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Figure 21. Mapping of PRC2 interacting domain in PHF1 
(A) Domain composition of PHF1 constructs (left) and their ability to form a stable complex with 
PRC2 (right): +, stable complex; (+), form a complex but the PHF1 construct itself is unstable;  
(-), the PHF1 construct is unstable, potentially does not form a complex; -, no complex 
formation. (B) SDS-PAGE analysis of various PHF1 constructs-PRC2 pull-downs; T, TEV 
protease; L, LPP; asterisks, PHF1 constructs. (C and D) Gel filtration profiles (top) and 
coomassie staining of gels (bottom) of PHF1Δloop-PRC2 (C) and PHF1(C)-PRC2 (D).  
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 After this screening, I further purified the two positive constructs 
(PHF1Δloop-PRC2 and PHF1(C)-PRC2) by the same procedure used for the 
purification of PHF1-PRC2 (Figure 20B). Both of the purified PHF1Δloop-PRC2 and 
PHF1(C)-PRC2 exhibit homogenous and stoichiometric complex indicated by gel 
filtration and SDS-PAGE analysis (Figure 21C and D).  
 Next, I performed the domain mapping in the PHF19 by using the same 
experimental setup used for the PHF1 constructs, and I observed that the PHF19 C-
terminal domain is also essential for the PHF19 to be associated with PRC2 (data not 
shown). Of note, the importance of the PHF19 C-terminal domain in interacting with 
SUZ12 has been described beforehand (Ballaré et al., 2012).  
 On the other hand, the Jones group suggested that the Pcl binds to the E(z) 
through two PHD fingers shown by yeast two hybrid (O'Connell et al., 2001). 
However, given by the structural analysis of this study, I noticed that the Pcl 
construct they used in that study spans from the PHD1 to the middle of WH domain 
(PclPHD1-PHD2-1/2WH), of which structural stability is presumably lacking. Moreover, in 
order to suggest that the Pcl PHD fingers are important for the interaction with the 
E(z), they mutated key residues coordinating Zn ions in the Pcl PHD fingers, which 
might have led to aggregation of the whole PclPHD1-PHD2-1/2WH construct. Furthermore, 
when I tried to reproduce their experiments by using a PclPHD1-PHD2-WH construct and 
various E(z) constructs, or the human counterparts, I could not obtain a stable 
complex (data not shown).   
 Interestingly, DNA sequencing analysis of the Dm strain Pcl22M21, which was 
generated by ethyl methanesulfonate (EMS) mutagenesis and described as an allele 
of Pcl (Gaytán de Ayala Alonso et al., 2007), showed that the Pcl22M21 strain has a 
mutation in the coding sequence of E701 to a stop codon (Nekrasov et al., 2007). I 
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thus examined whether the Pcl22M21 Dm embryo produces Pcl1-700 protein, which 
would contain all conserved domains but the C-terminal domain, by western blot 
analysis. The western blot analysis of heterozygous Pcl22M21 Dm embryo nuclear 
extracts shows that the truncated Pcl protein (Pcl1-700) is made in the Pcl22M21 Dm 
embryo (Figure 22). Therefore, the fact that the Pcl22M21 Dm shows a null Pcl 
phenotype is obviously due to the fact that Pcl1-700, without the C-terminal domain, is 
not be able to be integrated into the PRC2. 
 Therefore, these results manifest that the conserved C-terminal domains in 
Pcl homologues are crucial for the Pcl homologues to form a stable complex with 
PRC2. 
 
 
Figure 22. Whole nuclear extracts of 
heterozygous Pcl and wild-type Dm embryos 
A western blot analysis of whole nuclear extracts of the 
heterozygous Pcl (Pcl22M21/CyOUbiGFP) and the wild-
type (OregonR) Dm embryos (0 – 14 hours (hrs) after 
egg deposition). The Pcl22M21/CyOubiGFP Dm embryos 
show an extra band around 84kDa (asterisk), which 
corresponds to the size of Pcl1-700, by Pcl antibody. 
Nurf55 was probed as a loading control. 
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3. Additional DNA contact by PHF1 WH domain increases DNA 
binding of PRC2   
In order to examine the role of the DNA binding activity of PHF1 WH domain in 
the context of the PHF1-PRC2, I carried out microscale thermophoresis (MST) and 
native gel shift assays using various versions of recombinant PRC2 (i.e. PRC2, PHF1-
PRC2 and PHF1R304E/S307E/N310E/K323E/K324E-PRC2 (PHF1WH(E)-PRC2); Figure 23A). 
Unexpectedly, I observed that the PRC2 binds to DNA with high affinity shown by the 
MST (Kd: 218 nM; Figure 23B) and the native gel shift assay (Kd: 76 nM; Figure 23C - 
E), of which DNA binding activity has not been reported to date. The PHF1-PRC2 
shows higher affinity (Kd: 142 nM by MST and 25 nM by gel shift assay; Figure 23B - 
D) to DNA than the PRC2 does. As expected, the DNA binding affinity of PHF1WH(E)-
PRC2 is similar to the one of PRC2 (Figure 23B and C). Thus, these data indicate that 
the additional DNA contact by the PHF1 WH domain enhances the DNA binding of 
the PRC2. 
4. PHF1 WH and C-terminal domains enhance nucleosome binding of 
PRC2 
 I next questioned whether PHF1 enhances nucleosome binding of PRC2. The 
nucleosome binding activity of Dm PRC2 has been previously analysed by band shift 
assays. This earlier report showed that the Su(z)12 and the Nurf55 are the minimal 
requirement for the PRC2 to bind to the nucleosome, and the Esc increases the 
nucleosome binding affinity of the PRC2 (Nekrasov et al., 2005). In order to 
investigate the effect of the PHF1 on the nucleosome binding of PRC2, I first 
reconstituted Flc-labelled mononucleosomes, ensuring the absence of any uncoupled 
DNA to exclude the possibility of observing unspecific DNA binding of PRC2. I then 
measured the nucleosome binding activities of various PRC2 complexes (Figure 23A) 
by native gel shift assays (Figure 24). The PHF1-PRC2 binds to the nucleosome with 
the Kd of 51 nM, whereas PRC2 binds the nucleosome with Kd of 138 nM (Figure 24).  
 
63 
 
Figure 23. DNA binding activity of various versions of PRC2 
(A) Coomassie staining of a 13 % polyacrylamide-SDS gel containing various recombinant PRC2 
complexes used in Figure 23 to Figure 26; PHF1WH(A/E): point mutation on K323, K324, R304, 
S307, N310 to A or E.  (B) Quantitative measurements of DNA binding affinities of various PRC2 
complexes (from 4 nM to 4 μM) to 45 nM 30 bp Flc-DNA by Microscale thermophoresis (MST); 
dots represent the mean values of the triplicate measurements; error bars, standard deviation of 
the triplicates; curve fitting was performed by Hill function; Kd values in parenthesis. (C and D) 
Native gel shift assays of 30 bp Flc-DNA (45 nM) using various PRC2 complexes. (E) Binding 
curves were determined by densitometry of fluorescence signals obtained in the gel shift assays 
(see Figure 23C and D). 
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Mutation of the DNA binding residues in the WH domain slightly impairs the 
nucleosome binding (Figure 24), but the reduction is not as significant as the one 
shown in the DNA binding (Figure 23).  
 
Figure 24. Nucleosome binding activity of various PRC2 
Native gel shift assays of 45 nM mononucleosomes reconstituted with Flc-labelled  (A) 147 bp 
601 DNA (Nuc147) and (B) 215 bp 601 DNA (Nuc215) using various PRC2 complexes  
(from 17 nM to 4 μM). (C) Binding curves of various PRC2 complexes to Nuc147 were 
determined by densitometry of fluorescence signals obtained in the gel shift assays (see Figure 
24A and Figure 25).  
 I then queried whether this trait, which the effect of certain binding mutation 
is alleviated in the context of the nucleosome, could be found in other cases. Recently, 
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Justin et al. reported that the binding affinity of the histone H3 peptide harbouring 
the H3K27M mutation to PRC2 (Kd ~0.6 µM) is 20-fold higher than the one of the 
wild-type H3 peptide to the PRC2 (Kd ~13 µM) (Justin et al., 2016). I thus questioned 
whether the H3K27M mutation in the nucleosome (H3K27M nucleosome) increases 
the binding affinity to PRC2. To investigate this, I compared the binding affinity of 
the recombinant H3K27M nucleosome to the PRC2 with the one of the wild-type 
nucleosome to PRC2. I observed that the H3K27M mutation in the nucleosome 
slightly enhances the binding to the PRC2 (Figure 25), but the increase is not as 
significant as the one shown in the H3K27M peptide. This indicates that the H3K27M 
in the nucleosome increases the binding affinity to the PRC2 less efficiently than the 
H3K27M in the peptide does.  
 
Figure 25. Native gel shift assays of nucleosomes with PRC2 and PHF1(C)-PRC2 
Nuc (M): 45 nM H3K27M nucleosomes reconstituted with 147 bp DNA; Nuc: 45 nM wild-type 
nucleosomes with 147 bp DNA. 
 In addition, I observed that that the complex of the PRC2 and the nucleosome 
exhibits smeary bands in the native gel (Figure 24A, left, lanes of the concentration 
points of 0.3µM onwards), which imply highly dynamic interaction between the 
PRC2 and the nucleosome. Interestingly, however, the complex of the PHF1-PRC2 
and the nucleosome shows defined bands (Figure 24A, middle, lanes of the 
concentration points of 0.2 µM onwards), which implicate that the interaction 
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between the PHF1-PRC2 and the nucleosome is stable. Thus, it seems that the PHF1 
stabilizes the interaction between the PRC2 and the nucleosome. Intriguingly, 
however, the complex of the PHF1WH(E)-PRC2 and the nucleosome also exhibits 
defined bands in the native gel (Figure 24A, right, lanes of the concentration points of 
0.2µM onwards). This suggests that (an)other domain(s) of the PHF1 might be 
involved in stabilizing the association of PRC2 with the nucleosome. Since I 
determined that the PHF1 C-terminal domain is essential to form a stable complex 
with PRC2 (Figure 21), I investigated the influence of the PHF1 C-terminal domain 
on the nucleosome binding of PRC2. Interestingly, the complex of the PHF1(C)-PRC2 
and the nucleosome also exhibits the defined bands in the native gel (Figure 25), 
indicating that the PHF1 C-terminal domain is responsible for stabilizing the 
association of PRC2 with the nucleosome. Additional DNA binding assays show that 
the PHF1 C-terminal domain does not enhance the DNA binding of PRC2 (Figure 
23B and D), indicating that this stabilizing PRC2 binding to the nucleosome by the 
PHF1 C-terminal domain is the outcome of other properties than the DNA binding 
activity.  
 Together, these results strongly suggest that the combinational contribution 
of the PHF1 WH and the C-terminal domains enhances the nucleosome binding of 
PRC2. 
5. PHF1 WH and C-terminal domains are crucial for efficient H3K27 
methylation by PRC2 
 I next questioned whether the enhancement of nucleosome binding of PRC2 
by PHF1 WH and C-terminal domains is critical in promoting the H3K27 tri-
methylation by PRC2. In order to examine this, I performed in vitro HMTase assays 
on recombinant mononucleosomes using various versions of PRC2.  
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Figure 26. HMTase assays with various PRC2 complexes 
(A) HMTase assays on 446 nM mononucleosomes (with 215 bp DNA) of increasing amounts of 
various PRC2 with fixed incubation time (90 min) (left) or of fixed amounts of the various PRC2 
(192 nM) with increasing incubation time (right). (B) HMTase assay of various PRC2 complexes 
on 446 nM mononucleosomes (215 bp DNA) with fixed incubation time (90 min). (A and B) H4 
was probed as a loading control. Histograms represent band intensities of H3K27me3 bands. 
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 Firstly, the PHF1-PRC2 generates H3K27me3 more efficiently than the PRC2 
does (Figure 26), in agreement with the previous reports (Cao et al., 2008; Sarma et 
al., 2008). Further quantification analysis revealed that the PHF1-PRC2 exhibits 
approximately three-fold higher activity than the PRC2 (Figure 26). Importantly, the 
point mutation in DNA binding residues to Ala (PHF1WH(A)-PRC2) results in decrease 
of the H3K27me3 levels, and the mutation to Glu (PHFWH(E)-PRC2) causes even 
further reduction of the H3K27me3 levels (Figure 26A). Secondly, the PHF1(C)-PRC2 
generates higher levels of H3K27me3 than the PRC2 does (Figure 26B).    
 Thus, these results strongly support that enhancing the nucleosome binding 
of PRC2 by PHF1 WH and C-terminal domains is pivotal for the efficient H3K27 
methylation by PRC2. 
6. PHF1 does not alter the regulatory effect of in trans histone 
modifications on the PRC2 enzymatic activity 
 H3K27me3 binding in trans by EED aromatic cage and EZH2 SRM domain 
stimulates enzymatic activity of PRC2 (Jiao and Liu, 2015; Justin et al., 2016; 
Margueron et al., 2009). On the other hand, H3K36me3 binding in trans does not 
affect on PRC2 enzymatic activity. Only the H3K36me3 binding in cis (i.e. when the 
target nucleosome harbours H3K36me3) inhibits the PRC2 enzymatic activity 
(Schmitges et al., 2011).  
 In order to assess whether the regulation of the PRC2 HMTase activity by in 
trans histone modification is altered in the presence of the PHF1, I performed 
HMTase assays with PRC2 and PHF1-PRC2 by adding two different modified histone 
peptides (i.e. H319-35K27me3 and H328-43K36me3).  
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 The HMTase assay using PRC2 and additional histone peptides shows the 
consistency with the previous findings (Figure 27). Next, the HMTase assay of PHF1-
PRC2 in the presence of the histone peptides demonstrate the same trend as the one 
of PRC2, i.e., H319-35K27me3 peptides increase the HMTase activity of PHF1-PRC2, 
and H328-43K36me3 does not affect on the HMTase activity (Figure 28). I suppose 
that the inhibition observed in the last lane of Figure 28 is not well meaningful, 
because the concentration of H328-43K36me3 (267 µM) is much higher than the 
concentration of the substrate nucleosomes (446 nM).  
 Thus, these results show that PHF1 does not alter the regulatory effect of in 
trans histone modifications on the PRC2 enzymatic activity. 
 
 
Figure 27. HMTase assay of PRC2 with histone peptides 
A western-blot based HMTase assay on 446 nM mononucleosomes (reconstituted with 215 bp 
DNA) using 153 nM PRC2 with increasing amounts of H319-35K27me3 or H328-43K36me3 
peptides; H4 and SUZ12 were probed as a loading control. 
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Figure 28. HMTase assay of PHF1-PRC2 with histone peptides 
A western-blot based HMTase assay on 446 nM mononucleosomes (reconstituted with 215 bp 
DNA) using 153 nM PHF1-PRC2 with increasing amounts of histone peptides; H4 and SUZ12 
as a loading control. 
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IV. CONCLUSION AND DISCUSSION 
   Previous studies showed that the Pcl/PHF1 is required for efficient methylation of 
H3K27 by PRC2 (Cao et al., 2008; Nekrasov et al., 2007; Sarma et al., 2008). 
Structural and biochemical analyses of this study reveal that the Pcl/PHF1 reinforces 
nucleosome binding of PRC2 by the conserved WH and C-terminal domains, and that 
this is crucial for the efficient H3K27me3 by PRC2. This study thus provides a 
molecular rationale for how Pcl/PHF1 helps PRC2 generate H3K27me3 efficiently. 
1. A CLOSED AROMATIC CAGE OF THE PHD2 IN PCLP H D 2-W H 
 Aromatic cages in many PHD fingers function as epigenetic readers, which 
bind to modified histone tails (Sanchez and Zhou, 2011). However, the two 
independent crystal structures solved in this study (Table 12) showed that the 
aromatic cage of the Pcl PHD2 is closed by the phenyl-ring of the Phe523 (Figure 18). 
The corresponding residue of the Phe523 in mammalian Pcl proteins is Trp (Figure 
17), which seems to ensure its closure with the bulkier residue during the course of its 
evolution. Still, there could be a chance that the closed aromatic cage in the PHD2 is 
a regulatory element of the Pcl, which could be opened conditionally. For example, 
additional domains of the Pcl protein itself or from the PRC2 core subunits, in the 
context of the full-length Pcl-PRC2 complex, might alter the conformation of the 
aromatic cage to permit the potential ligand binding. Solving a high-resolution 
structure of the Pcl together with PRC2 could provide a decisive answer to this 
question. 
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2. MILD DNA BINDING ACTIVITY OF THE WH DOMAIN IN 
PCLP H D 2-W H 
 This study demonstrated the presence of the WH domain adjacent to the 
PHD2 in Pcl by the crystal structure of Pcl construct (Figure 17). In addition, this 
study showed that the Pcl WH domain binds DNA in a sequence non-specific fashion 
(Figure 19). One similar example of this is the case of ASH2L WH domain. ASH2L is 
a core subunit of MLL family histone methyltransferase, which methylates histone 
H3K4 (Ruthenburg et al., 2007). The ASH2L WH domain also folds next to the PHD 
finger domain, and binds to DNA in a sequence non-specific manner with mild 
affinity (Chen et al., 2011; Sarvan et al., 2011).  
 One possible explanation for this could be that because both Pcl and ASH2L 
are a component of multi-subunit histone methyltransferase complex (PRC2 and 
MLL respectively), the WH domains of Pcl and ASH2L might not need to take the 
whole responsibility to bind the target DNA. Rather, the responsibility might be 
shared among the subunits of the complex, and all the contributions from the 
subunits could be added up in order to exert the optimal binding to the target DNA. 
3. UNVEILED DNA BINDING ACTIVITY OF PRC2 
 This study revealed, for the first time to my knowledge, the direct DNA 
binding activity of PRC2 (Figure 23). Indeed, the Su(z)12 ZnF domain has been 
suggested to bind to the PRE region in vivo, although the ZnF domain is dispensable 
in histone methyltransferase activity in vitro (Rai et al., 2013). In addition, the EZH2 
includes two SANT domains, which exhibit similarity to the DNA binding domain of 
Myb-related proteins (Boyer et al., 2004).  
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 Several reports provided the lncRNA binding activity of PRC2 (reviewed in 
Davidovich and Cech, 2015). The common consensus from the reports could be 
merged to sequence non-specificity of PRC2 in the lncRNA binding. In addition, 
recent UV cross-linking followed by IP (CLIP; Hafner et al., 2010) experiments 
showed that the SUZ12 binds to RNA directly with or without PRC2 (Beltran et al., 
2016). The DNA binding affinity of PRC2 obtained in this study is comparable to the 
RNA binding affinity of PRC2 described in the other study (Davidovich et al., 2013). 
Davidovich et al. showed that the PRC2 binds to lncRNA with higher affinity in low 
salt buffer conditions (Davidovich et al., 2013). Thus, I suggest that PRC2 binds to 
nucleic acids promiscuously perhaps mainly via charge-based phosphate backbone 
contact.  
 This finding of DNA binding activity of PRC2 seems to reinforce the point 
discussed in the section IV.2 (p. 72), that the DNA binding activity required for the 
complex could be distributed amongst Pcl and the other PRC2 subunits. Of note, the 
Pcl homologue strengthens DNA binding affinity of PRC2 by two fold (Figure 23). 
4. INDISPENSABLE ROLES OF THE PHF1 C-TERMINAL 
DOMAIN IN PHF1-PRC2 
 This study uncovered two important features of the PHF1 C-terminal domain: 
(i) interacting with PRC2 (Figure 21) and (ii) stabilizing the nucleosome binding of 
PRC2 (Figure 24), which is critical to promote the histone methyltransferase activity 
of PRC2 (Figure 26).  
 Ballàre et al. demonstrated that the C-terminal domains of Pcl homologues 
exhibit a ‘reversed chromodomain’ structure by secondary structure prediction 
analysis (Ballaré et al., 2012). Canonical chromodomains are comprised of three β-
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sheets and one following α-helix (Figure 29A). The C-terminal domains of Pcl 
homologues are suggested to contain one α-helix and two following β-sheets (Ballaré 
et al., 2012). Most chromodomains have been reported for their ability to bind to 
methylated lysines or nucleic acids via the aromatic cage with three conserved 
hydrophobic residues (Figure 29B; Eissenberg, 2012). Interestingly, the C-terminal 
domains of Pcl homologues have the conserved Trp in β2 in all Pcl homologues, 
implying its potential to form an aromatic cage. 
 
Figure 29. Similarity of PHF1 C-terminal domain to the HP1 chromodomain 
(A) Sequence alignment of the HP1 chromodomain and Pcl C-terminal domain; secondary 
structural elements of HP1 were depicted in green by the crystal structure shown in (B); 
secondary structural elements of Pcl homologues were drawn in brown by secondary structure 
prediction; asterisks indicate the residues involved in forming an aromatic cage of HP1. (B) A 
crystal structure of the HP1 chromodomain with the H3 peptide harbouring K9me3 (PDB code: 
1KNE). 
 I currently do not understand how the PHF1 C-terminal domain stabilizes the 
association of PRC2 with the nucleosome. I speculate (i) that a part of the C-terminal 
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domain might bind to PRC2 and the other part to the nucleosome or (ii) that the C-
terminal domain might alter the conformation of PRC2 to allow the PRC2 to bind to 
the nucleosome more stably. High-resolution structure of PHF1(C)-PRC2 onto the 
NCP could provide an insight on this.  
5. PCL AND PRC2 RECRUITMENT 
 Previous ChIP analysis showed the reduced PRC2 recruitment to the 
Polycomb targets in the murine Pcl-knockdown cells (Cao et al., 2008; Casanova et 
al., 2011) and in the Pcl-/- Drosophila embryo (Nekrasov et al., 2007), suggesting that 
Pcl/Phf1 facilitates the recruitment of PRC2. However, I could not find any evidence 
of sequence specificity of DNA binding by the Pcl WH domain. I propose that 
stabilizing the association of PRC2 with the nucleosome by Pcl homologues could 
have permitted capturing more abundant PRC2 during the ChIP procedure in the 
wild type than in the Pcl homologue mutants. In other words, I suggest that the Pcl 
homologues are responsible for anchoring PRC2 to the nucleosome stably, rather 
than de-novo recruitment. However I cannot exclude the possibility that Pcl might be 
involved in the PRC2 recruitment by different mechanism via other domains.   
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Esc  Extra sex combs 
ES  Embryonic stem 
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lncRNA long non-coding RNA 
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mES  mouse embryonic stem  
MS  Mass spectrometry 
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Nurf55  Nucleosome-remodelling factor 55 kDa subunit 
OD600  optical density at 600 nm  
PAGE  polyacrylamide gel electrophoresis  
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PcG  Polycomb group  
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PDB  Protein data bank  
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PRC1  Polycomb repressor complex-1  
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Su(z)12 Suppressor of zeste 12 
TrxG   Trithorax group 
Ub   Ubiquitin 
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Zn  Zinc  
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APPENDIX 
 
The tables below show the list of clones generated and used for crystallization trials 
or biochemical studies during the PhD study, but not described in this thesis. All 
abbreviation is the same as ones in Table 4. 
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